As filed with the Securities and Exchange Commission on November 28, 2007
                                                  Registration No. 333-140929

================================================================================
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                               -----------------

                               AMENDMENT NO. 2 TO

                                    FORM SB-2
                             REGISTRATION STATEMENT
                                    UNDER THE
                             SECURITIES ACT OF 1933

                                -----------------

                        ENVIRO VORAXIAL TECHNOLOGY, INC.
                        --------------------------------
                 (Name of Small Business Issuer in Its Charter)

            Idaho                           3559                  82-0266517
            -----                           ----                  ----------
(State or Other Jurisdiction of (Primary Standard Industrial   (I.R.S. Employer
 Incorporation or Organization)     Classification Number)   Identification No.)

                                821 NW 57th Place
                            Fort Lauderdale, FL 33309
                                 (954) 958-9968
          (Address and Telephone Number of Principal Executive Offices)

                                -----------------

                       A. DiBella, Chief Executive Officer
                                821 NW 57th Place
                            Fort Lauderdale, FL 33309
                                 (954) 958-9968
            (Name, Address and Telephone Number of Agent for Service)

                                -----------------

                        Copies of all communications to:

                             Brian A. Pearlman, Esq.
                               Arnstein & Lehr LLP
                     200 East Las Olas Boulevard, Suite 1700
                         Fort Lauderdale, Florida 33301
                            Telephone: (954) 713-7600
                          Facsimile No. (954) 713-7700

                                -----------------

         Approximate Date of Proposed Sale to the Public: As soon as practicable
after the effective date of this Registration Statement.

         We hereby amend this Registration Statement on such date or dates as
may be necessary to delay its effective date until we file a further amendment
which specifically states that this Registration Statement shall thereafter
become effective in accordance with Section 8(a) of the Securities Act of 1933,
as amended, or until the Registration Statement shall become effective on such
date as the Securities and Exchange Commission, acting under Section 8(a), may
determine.

         If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. [ ]

         If this Form is a post-effective amendment filed pursuant to Rule
462(c) under the Securities Act, check the following box and list the Securities
Act registration statement number of the earlier effective registration
statement for the same offering. [ ]

         If this Form is a post-effective amendment filed pursuant to Rule
462(d) under the Securities Act, check the following box and list the Securities
Act registration number of the earlier effective registration statement for the
same offering. [ ]

         If delivery of the prospectus is expected to be made pursuant to Rule
434, please check the following box. [ ]


                                -----------------



                                      CALCULATION OF REGISTRATION FEE

                                                                            Proposed         Proposed
            Title of Each                                                    Maximum          Maximum        Amount of
         Class of Securities                            Amount to be     Offering Price      Aggregate     Registration
          to be Registered                               Registered       Per Security    Offering Price        Fee
          ----------------                               ----------       ------------    --------------        ---
                                                                                                   
Common stock, par value $0.001 per share(1)......          265,250            $0.75        $198,937.50          6.11
                                                         4,213,581            $1.00      $4,213,581.00        129.36
                                                           516,666            $1.25        $645,832.50         19.83
                                                           100,000            $3.00        $300,000.00          9.21
                                                           100,000            $4.00        $400,000.00         12.28
                                                           121,600            $6.00        $729,600.00         22.40
                                                           121,600            $9.00      $1,094,400.00         33.60
                                                           697,333            $0.60        $418,399.80         12.84
                                                            30,000            $0.71         $21,300.00          0.65
                                                           200,000            $0.77        $154,000.00          4.73
                                                           150,000            $0.80        $120,000.00          3.68
                                                           225,000            $0.80        $180,000.00          5.53
                                                           757,333            $1.00        $757,333.00         23.25
Common stock, par value $0.001 per share(2)......        2,000,000            $0.15        $300,000.00(2)       9.21
                                                            45,000            $0.30         $13,500.00(2)       0.41
Total Registration Fee                                                                   $9,546,883.80      $ 293.09(3)

-----------------
(1)    Estimated solely for purposes of calculating the registration fee
       pursuant to Rule 457(g). Shares issuable upon exercise of warrants and
       options based upon the exercise price of the respective option or
       warrant, which is higher than the closing price for the common stock on
       February 23, 2007.
(2)    Estimated solely for purposes of calculating the registration fee
       pursuant to Rule 457(g). Shares issuable upon exercise of warrants and
       options. Based upon the closing price for the common stock on February
       23, 2007 ($0.54 as reported on the OTCBB), which is higher than the
       exercise price of the respective option or warrant.
(3)    Fee paid.
-----------------

         Information contained herein is subject to completion or amendment. A
registration statement relating to these securities has been filed with the
Securities and Exchange Commission. These securities may not be sold nor may
offers to buy be accepted prior to the time the registration statement becomes
effective. This prospectus shall not constitute an offer to sell or the
solicitation of an offer to buy nor shall there by any sale of these securities
in any state in which such offer, solicitation or sale would be unlawful prior
to registration or qualification under the securities laws of any such state.




The information in this prospectus is not complete and may be changed. We may
not sell these securities until the registration statement filed with the
Securities and Exchange Commission is effective. This prospectus is not an offer
to sell the securities and it is not soliciting an offer to buy these securities
in any state where the offer or sale is not permitted.
================================================================================

                 SUBJECT TO COMPLETION: DATED NOVEMBER 28, 2007

PROSPECTUS

                        ENVIRO VORAXIAL TECHNOLOGY, INC.

                                9,543,363 SHARES



         This prospectus covers 9,543,363 shares of common stock of Enviro
Voraxial Technology, Inc. being offered for resale by certain selling
shareholders. All of these shares represent shares underlying outstanding
options and warrants. We are paying the expenses incurred in registering the
shares, which may be offered by the selling shareholders, but all selling and
other expenses incurred by the shareholders will be borne by the selling
shareholders.

         The securities may be sold by the shareholders to or through
underwriters or dealers, directly to purchasers or through agents designated
from time to time. For additional information on the methods of sale, you should
refer to the section entitled "Plan of Distribution" in this prospectus.

         Our common stock is quoted on the OTCBB under the trading symbol
"EVTN". Prior to the date of this prospectus there has been limited trading
activity for our common stock and the market for our shares has been illiquid.
On April 19, 2007, the closing price for our common stock was $0.73.

THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. YOU SHOULD PURCHASE SHARES ONLY
IF YOU CAN AFFORD A COMPLETE LOSS OF YOUR INVESTMENT. SEE "RISK FACTORS"
BEGINNING ON PAGE 3.

NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES
COMMISSION HAS APPROVED OR DISAPPROVED THESE SECURITIES, OR DETERMINED IF THIS
PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A
CRIMINAL OFFENSE.




                               PROSPECTUS SUMMARY

         This summary contains what we believe is the most important information
about us and the offering. You should read the entire document for a complete
understanding of our business and the transactions in which we are involved. The
purchase of the securities offered by this prospectus involves a high degree of
risk. See the "Risk Factors" section of this prospectus for risk factors. Unless
otherwise indicated, information in this prospectus (excluding our financial
statements) gives effect to our recent offerings.

                                  INDUSTRY DATA

         Information contained in this prospectus concerning our industry, the
markets for our products and the historic growth rate of, and our position in,
those markets, is based on estimates that we prepared using data from various
sources (including industry publications, surveys and forecasts and our internal
research), on assumptions that we have made that are based on that data and
other similar sources and our knowledge of the markets for our products. We take
responsibility for compiling and extracting, but have not independently
verified, market and industry data provided by third parties, or by industry or
general publications. Similarly, while we believe our internal estimates are
reliable, our estimates have not been verified by any independent sources, and
we cannot assure you as to their accuracy.

                             DESCRIPTION OF BUSINESS

         Enviro Voraxial Technology, Inc. (the "Company") was incorporated in
Idaho on October 19, 1964. In May of 1996, we entered into an agreement and plan
of reorganization with a privately held Florida corporation, Florida Precision
Aerospace, Inc. ("FPA"), and its shareholders. FPA was incorporated on February
26, 1993. We exchanged approximately 97% of our shares then issued and
outstanding for all of the issued and outstanding shares of FPA. As a result of
this reorganization, the shareholders of FPA gained control of our company and
FPA became our wholly owned subsidiary. At the close of the transaction, we
changed our name to Enviro Voraxial Technology, Inc. Our executive offices are
located at 821 N.W. 57th Place, Fort Lauderdale, Florida 33309. Our telephone
number is 954-958-9968.

         The Voraxial(R) Separator is a continuous flow turbo machine that
generates a strong centrifugal force, a vortex, capable of separating light and
heavy liquids, such as oil and water, or any other combination of liquids and
solids at extremely high flow rates. As the fluid passes through the machine,
the Voraxial(R) Separator accomplishes this separation through the creation of a
vortex. In liquid/liquid and liquid/solid mixtures, this vortex causes the
heavier compounds to gravitate to the outside of the flow and the lighter
elements to move to the center where an inner core is formed. The liquid stream
processed by the machine is divided into separate streams of heavier and lighter
liquids and solids. As a result of this process, separation is achieved.

         To date we have had limited revenues and have an accumulated deficit at
December 31, 2006 of $6,715,536. However, we believe we are emerging as a
potential leader in the rapidly growing environmental and industrial separation
industries. The Company has developed and patented the Voraxial(R) Separator; a
proprietary technology that efficiently separates large volumes of
liquid/liquid, liquid/solids or liquid/liquid/solids with distinct specific
gravities. Management believes this superior separation quality is achieved in
real-time, and in much greater volumes, with a more compact, cost efficient and

                                       1

energy efficient machine than any comparable product on the market today. The
Voraxial(R) Separator operates in-line and is scaleable.

         The Company is presently researching and developing Voraxial(R)
solutions for various applications and markets including oil-water separation
and oil exploration and production.

                                  THE OFFERING

         This prospectus covers up to 9,543,363 shares of our common stock,
which may be sold by the selling shareholders identified in this prospectus. Of
these shares, 5,438,698 shares are underlying warrants exercisable at the
following prices:

      265,250 shares are underlying warrants exercisable at $0.75 per share,
      4,213,582 shares are underlying warrants exercisable at $1.00 per share,
      516,666 shares are underlying warrants exercisable at $1.25 per share,
      100,000 shares are underlying warrants exercisable at $3.00 per share,
      100,000 shares are underlying warrants exercisable at $4.00 per share,
      121,600 shares are underlying warrants exercisable at $6.00 per share, and
      121,600 shares are underlying warrants exercisable at $9.00 per share.

The remaining 4,104,666 shares are underlying options exercisable at the
following prices:

      2,000,000 shares are underlying options exercisable at $0.15 per share,
      45,000 shares are underlying options exercisable at $0.30 per share,
      697,333 shares are underlying options exercisable at $0.60 per share,
      30,000 shares are underlying options exercisable at $0.71 per share,
      200,000 shares are underlying options exercisable at $0.77 per share,
      150,000 shares are underlying options exercisable at $0.80 per share,
      225,000 shares are underlying options exercisable at $0.80 per share, and
      757,333 shares are underlying options exercisable at $1.00 per share.

      While we will not receive any proceeds from sales of shares of our common
stock by the selling shareholders, the Company will receive up to $11,166,883.80
from shares issued upon exercise of any warrants or options. The proceeds from
the exercise of warrants and options will be used for general working capital
purposes. The warrants and options expire on various dates between February 2007
and June 2009. In addition, the warrants are callable at a closing bid price of
$0.001 per underlying Common Share provided the Company's Common Stock trades at
or above $2.00 per share based for twenty consecutive trading days within 30
days of the Company's written notice of the Company's intention to call this
warrant. In the event this warrant has not been exercised by written notice
within 30 days of such notice, this warrant will cease to exist.

         As of September 30, 2007, there are 22,872,235 shares of our common
stock outstanding. This number of outstanding shares excludes: 5,438,698 shares
of our common stock underlying warrants and 4,104,666 shares of common stock
underlying stock options issued to our employees and consultants.










                                        2

                     SUMMARY FINANCIAL AND STATISTICAL DATA

         The financial data set forth below under the captions "Results of
Operations Data" and "Balance Sheet Data" as of December 31, 2006 and for the
year ended December 31, 2006 are derived from our audited financial statements,
included elsewhere in this Prospectus, by Jewett, Schwartz & Associates & Co.,
LLP independent public accountants. The financial data set forth below should be
read in conjunction with the financial statements and notes thereto included
elsewhere in this Prospectus and "Management's Discussion and Analysis of
Financial Condition and Results of Operations."



RESULTS OF OPERATIONS DATA

                                              For the Year Ended
                                        December 31,          December 31,
                                            2005                  2006
                                            ----                  ----
                                                          
Net sales.....................           $  128,070           $  310,376
Cost of sales.................           $   34,444           $  134,499
Gross profit..................           $   93,626           $  175,877
Operating expenses............           $1,186,773           $1,014,156
Net loss......................          ($1,093,147)         ($  838,279)

Weighted average number of
   common shares outstanding:
   Basic & Diluted............           18,257,808           18,257,808

Net loss per common share:
   Basic & Diluted                           ($0.06)              ($0.05)




BALANCE SHEET DATA

                                                    December 31, 2006
                                                    -----------------

                                                      
Working capital (deficit)..........................        ($   1,822)
Total assets.......................................         $ 664,635
Total liabilities..................................         $ 651,702
Shareholders' equity...............................        ($  12,933)











                                       3

                           FORWARD LOOKING STATEMENTS

         The discussion in this Prospectus regarding our business and operations
includes "forward-looking statements" which consist of any statement other than
a recitation of historical fact and can be identified by the use of
forward-looking terminology such as "may," "expect," "anticipate," "estimate" or
"continue" or the negative thereof or other variations thereon or comparable
terminology. The reader is cautioned that all forward-looking statements are
speculative, and there are certain risks and uncertainties that could cause
actual events or results to differ from those referred to in such
forward-looking statements. This disclosure highlights some of the important
risks regarding our business. The risks included should not be assumed to be the
only things that could affect future performance. Additional risks and
uncertainties include the potential loss of contractual relationships,
fluctuations in the volume of sales we make or transactions processed by our
customers, as well as uncertainty about the ability to collect the appropriate
amounts due to us.

                                  RISK FACTORS

OUR INDEPENDENT AUDITORS HAVE RAISED SUBSTANTIAL DOUBT ABOUT OUR ABILITY TO
CONTINUE AS A GOING CONCERN.

         Although we operated as a precision machine shop for a number of years,
we have only recently completed the development of the Voraxial Separator, and
we have not yet generated significant revenues from that product. As a result,
we have limited operating history in our planned business upon which you may
evaluate our business and prospects. The revenues and income potential of our
business and the markets of our separation technology are unproven. Our business
plan must be considered in light of risks, expenses, delays, problems, and
difficulties frequently encountered by development stage companies.

         We have incurred operating losses since our inception, and we will
continue to incur net losses until we can produce sufficient revenues to cover
our costs. At September 30, 2007 we had an accumulated deficit of $8,232,163. At
December 31, 2006, we had an accumulated deficit of $6,715,536, including a net
loss of $833,531 for the year ended December 31, 2006. Even if we achieve
profitability, we may not be able to sustain or increase our profitability on a
quarterly or annual basis.

         Our ability to generate future revenues will depend on a number of
factors, many of which are beyond our control. These factors include the rate of
market acceptance of our products, competitive efforts, and general economic
trends. Due to these factors, we cannot anticipate with any degree of certainty
what our revenues will be in future periods. You have limited historical
financial data and operating results with which to evaluate our business and our
prospects. As a result, you should consider our prospects in light of the early
stage of our business in a new and rapidly evolving market.

         Our independent auditors have included in their audit report an
explanatory paragraph that states that our continuing losses from operations
raises substantial doubt about our ability to continue as a going concern.








                                       4

WE HAVE BEEN LIMITED BY INSUFFICIENT CAPITAL, AND WE MAY CONTINUE TO BE SO
LIMITED.

         In the past, we have lacked the required capital to market the Voraxial
Separator. Our inability to raise the funding or to otherwise finance our
capital needs could adversely affect our financial condition and our results of
operations, and could prevent us from implementing our business plan.

         We may seek to raise capital through public and private equity
offerings, debt financing or collaboration, and strategic alliances. Such
financing may not be available when we need it or may not be available on terms
that are favorable to us. If we raise additional capital through the sale of our
equity securities, your ownership interest will be diluted and the terms of the
financing may adversely affect your holdings or rights as a stockholder.

OUR BUSINESS MODEL IS UNPROVEN AND IF IT IS NOT SUCCESSFULLY IMPLEMENTED, OUR
BUSINESS WILL FAIL.

         Our business model is currently unproven and in the early stages of
development and we have not yet undertaken any substantial marketing activities.
The technological, marketing, and other aspects of our business will require
substantial resources and will undergo constant developmental change. Our
ability to develop a successful business model will be dependent upon the
relative success or failure of these respective aspects of our operations and
how effectively they work in concert with one another. If we expend significant
financial and management resources attempting to market the Voraxial Separator
to a specific industry segment, and we subsequently are unsuccessful in
generating sales from that segment, we may not have enough resources to market
to other industry segments. There are no assurances that we will successfully
develop our business model from the standpoint of successfully implementing an
efficient and effective marketing plan.

IF OUR PRODUCTS DO NOT ACHIEVE AND MAINTAIN MARKET ACCEPTANCE, OUR BUSINESS
WILL NOT BE SUCCESSFUL.

         Even though we believe our product is successfully developed, our
success and growth will depend upon its acceptance by various potential users of
our product. Acceptance will be a function of our product being more cost
effective as compared to currently existing or future technologies. If our
product does not achieve market acceptance, our business will not be successful.
In addition, even if our product achieves market acceptance, we may not be able
to maintain that market acceptance over time if new products or technologies are
introduced that are more favorably received than our product or render our
products obsolete.

IF WE DO NOT DEVELOP SALES AND MARKETING CAPABILITIES OR ARRANGEMENTS
SUCCESSFULLY, WE WILL NOT BE ABLE TO COMMERCIALIZE OUR PRODUCT SUCCESSFULLY.

         We have limited sales and marketing experience. We may market and sell
our product through a direct sales force or through other arrangements with
third parties, including co-promotion arrangements. Since we may market and sell
any product we successfully develop through a direct sales force, we will need
to hire and train qualified sales personnel.








                                       5

OUR MARKET IS SUBJECT TO INTENSE COMPETITION. IF WE ARE UNABLE TO COMPETE
EFFECTIVELY, OUR PRODUCT MAY BE RENDERED NON-COMPETITIVE OR OBSOLETE.

         We are engaged in a segment of the water filtration industry that is
highly competitive and rapidly changing. Many large companies, academic
institutions, governmental agencies, and other public and private research
organizations are pursuing the development of technology that can be used for
the same purposes as our product. We face, and expect to continue to face,
intense and increasing competition, as new products enter the market and
advanced technologies become available. We believe that a significant number of
products are currently under development and will become available in the future
that may address the water filtration segment of the market. If other products
are successfully developed, it may be marketed before our product.

         Our competitors' products may be more effective, or more effectively
marketed and sold, than any of our products. Many of our competitors have:

         o     significantly greater financial, technical and human resources
               than we have and may be better equipped to discover, develop,
               manufacture and commercialize products; and

         o     more extensive experience in marketing water treatment products.

         Competitive products may render our products obsolete or noncompetitive
before we can recover the expenses of developing and commercializing our
product. Furthermore, the development of new technologies and products could
render our product noncompetitive, obsolete, or uneconomical.

AS WE EVOLVE FROM A COMPANY PRIMARILY INVOLVED IN DESIGN AND DEVELOPMENT TO ONE
ALSO INVOLVED IN COMMERCIALIZATION, WE MAY ENCOUNTER DIFFICULTIES IN MANAGING
OUR GROWTH AND EXPANDING OUR OPERATIONS SUCCESSFULLY.

         We may experience a period of rapid and substantial growth that may
place a strain on our administrative and operational infrastructure, and we
anticipate that continued growth could have a similar impact. As our product
continues to enter and advance in the market, we will need to expand our
development, regulatory, manufacturing, marketing and sales capabilities or
contract with third parties to provide these capabilities for us. As our
operations expand, we expect that we will need to manage additional
relationships with various collaborative partners, suppliers, and other third
parties.

IF WE ARE UNABLE TO ADEQUATELY PROTECT OUR TECHNOLOGY, OR IF WE INFRINGE THE
RIGHTS OF OTHERS, WE MAY NOT BE ABLE TO DEFEND OUR MARKETS OR TO SELL OUR
PRODUCT.

         Our success may depend in part on our ability to continue and expand
our patent protection both in the United States and in other countries for our
product. Due to evolving legal standards relating to the patentability,
validity, and enforceability of patents covering our product and the scope of
claims made under these patents, our ability to obtain and enforce patents is
uncertain and involves complex legal and factual questions. Accordingly, rights
under any issued patents may not provide us with sufficient protection for our








                                       6

product or provide sufficient protection to afford us a commercial advantage
against competitive products or processes.

         Our success may also depend in part on our ability to operate without
infringing the proprietary rights of third parties. The manufacture, use, or
sale of our product may infringe on the patent rights of others. Likewise, third
parties may challenge or infringe upon our existing or future patents.
Proceedings involving our patents or patent applications or those of others
could result in adverse decisions regarding:

         o     the patentability of our inventions relating to our product;
               and/or

         o     the enforceability, validity, or scope of protection offered by
               our patents relating to our product.

         Litigation may be necessary to enforce the patents we own and have
applied for (if they are awarded), copyrights, or other intellectual property
rights, to protect our trade secrets, to determine the validity and scope of the
proprietary rights of others, or to defend against claims of infringement. This
type of litigation could result in the expenditure of significant financial and
managerial resources and could result in injunctions preventing us from
distributing certain products. Such claims could materially adversely affect our
business, financial condition, and results of operations.

WE ARE DEPENDENT ON KEY PERSONNEL AND THE LOSS OF THE SERVICES OF ANY SUCH
PERSONNEL COULD HAVE A MATERIAL ADVERSE EFFECT ON US.

         We are dependent upon the availability and the continued performance of
the services of Alberto DiBella and John DiBella. The loss of the services of
any such personnel could have a material adverse effect on us. In addition, the
availability of skilled personnel is extremely important to our growth strategy
and our failure to attract and retain such personnel could have a material,
adverse effect on us. We do not currently maintain any key man life insurance
covering these persons.

OUR OPERATIONS ARE SUBJECT TO GOVERNMENTAL APPROVALS AND REGULATIONS AND
ENVIRONMENTAL COMPLIANCE, WHICH MAY SUBJECT US TO INCREASING OPERATIONAL COSTS.

         Our operations are subject to extensive and frequently changing
federal, state, and local laws and substantial regulation by government
agencies, including the United States Environmental Protection Agency (EPA), the
United States Occupational Safety and Health administration (OSHA) and the
Federal Aviation Administration (FAA). Among other matters, these agencies
regulate the operation, handling, transportation and disposal of hazardous
materials used by us during the normal course of our operations, govern the
health and safety of our employees and certain standards and licensing
requirements for our aerospace components that we contract manufacture. We are
subject to significant compliance burden from this extensive regulatory
framework, which may substantially increase our operational costs.

         We believe that we have been and are in compliance with environmental
requirements and believe that we have no liabilities under environmental
requirements. Further, we have not spent any funds specifically on compliance







                                        7

with environmental laws. However, some risk of environmental liability is
inherent in the nature of our business, and we might incur substantial costs to
meet current or more stringent compliance, cleanup, or other obligations
pursuant to environmental requirements in the future. This could result in a
material adverse effect to our results of operations and financial condition.

OUR BUSINESS HAS A SUBSTANTIAL RISK OF PRODUCT LIABILITY CLAIMS. IF WE ARE
UNABLE TO OBTAIN APPROPRIATE LEVELS OF INSURANCE, A PRODUCT LIABILITY CLAIM
AGAINST US COULD AVERSELY AFFECT OUR BUSINESS.

         Our business exposes us to possible claims of personal injury, death,
or property damage, which may result from the failure, or malfunction of any
component or subassembly manufactured or assembled by us. While we have product
liability insurance, any product liability claim made against us may have a
material adverse effect on our business, financial condition, or results of
operations in light of our poor financial condition, losses and limited
revenues.

OUR SHARES OF COMMON STOCK HAVE TRADED ON A LIMITED BASIS AND YOU MAY FIND IT
DIFFICULT TO DISPOSE OF YOUR SHARES OF OUR STOCK, WHICH COULD CAUSE YOU TO LOSE
ALL OR A PORTION OF YOUR INVESTMENT IN OUR COMPANY.

         Our shares of common stock are currently quoted on the OTC Bulletin
Board. The trading in shares of our common stock has been limited and we
anticipate the trading market in the foreseeable future will continue to be
limited. As a result, you may find it difficult to dispose of shares of our
common stock and you may suffer a loss of all or a substantial portion of your
investment in our common stock.

OUR COMMON STOCK IS COVERED BY SEC "PENNY STOCK" RULES WHICH MAY MAKE IT MORE
DIFFICULT FOR YOU TO SELL OR DISPOSE OF OUR COMMON STOCK, WHICH COULD CAUSE YOU
TO LOSE ALL OR A PORTION OF YOUR INVESTMENT IN OUR COMPANY.

         Our common stock is covered by an SEC rule that imposes additional
sales practice requirements on broker-dealers who sell such securities to
persons other than established customers and accredited investors, which are
generally institutions with assets in excess of $5,000,000, or individuals with
net worth in excess of $1,000,000 or annual income exceeding $200,000 or
$300,000 jointly with their spouse. For transactions covered by the rule, the
broker-dealer must make a special suitability determination for the purchaser
and transaction prior to the sale. Consequently, the rule may affect the ability
of broker-dealers to sell our securities, and also may affect the ability of
purchasers of our stock to sell their shares in the secondary market. It may
also diminish the number of broker-dealers that may be willing to make a market
in our common stock, and it may affect the level of news coverage we receive.

FUTURE SALES BY OUR STOCKHOLDERS MAY NEGATIVELY AFFECT OUR STOCK PRICE AND OUR
ABILITY TO RAISE FUNDS IN NEW STOCK OFFERINGS.

         Sales of our common stock in the public market following this offering
could lower the market price of our common stock due to the additional shares in
the market. Sales may also make it more difficult for us to sell equity
securities or equity-related securities in the future at a time and price that
our management deems acceptable or at all.

THE EXERCISE OF THE WARRANTS AND OPTIONS COULD NEGATIVELY AFFECT THE MARKET
PRICE FOR OUR COMMON STOCK.

         To the extent that holders of the options or warrants exercise such
convertible securities and then sell the underlying shares of common stock in
the open market, our common stock price may decrease due to the additional
shares in the market.
                                        8

                                 CAPITALIZATION

         The following tables set forth our capitalization as of December 31,
2006. The tables should be read in conjunction with our consolidated financial
statements and related notes included elsewhere in this prospectus.



                               December 31, 2006
                               ------------------
                                                                                                    
Long-term debt...................................................................................      $           0
Current Liabilities .............................................................................            651,702
Shareholders' equity:
   Preferred Stock; 7,250,000 authorized;
     Shares authorized, 0 Shares issued and outstanding..........................................                  0
   Common stock; $0.001 par value; 42,750,000
     Shares authorized; 21,992,235 shares issued and outstanding.................................             21,991
   Additional paid-in capital....................................................................          6,719,811
   Deferred compensation ........................................................................             13,333
   Accumulated deficit...........................................................................         (6,715,536)
                                                                                                       -------------
Total shareholders' equity.......................................................................      $     (12,933)
                                                                                                       =============
Total liabilities and shareholders equity........................................................      $     664,635
                                                                                                       =============


































                                        9

                 PRICE RANGE OF COMMON STOCK AND DIVIDEND POLICY

         Our common stock is quoted on the NASDAQ Over-The-Counter Bulletin
Board ("OTCBB") under the symbol EVTN. There is no assurance that an active
trading market will develop which will provide liquidity for our existing
shareholders or for persons who may acquire common stock through the exercise of
warrants and options. On November 21, 2007, the closing price for our common
stock was $0.75. The quotations reflect inter-dealer prices, without retail
mark-up, markdown or commission, and may not represent actual transactions.

BID QUOTATIONS

                  Quarter Ended                  High               Low
                  -------------                  ----               ---

                  March 31, 2005                 $0.85             $0.42
                  June 30, 2005                  $0.60             $0.38
                  September 30, 2005             $0.85             $0.41
                  December 31, 2005              $0.70             $0.45

                  March 31, 2006                 $0.70             $0.50
                  June 30, 2006                  $0.79             $0.48
                  September 30, 2006             $0.60             $0.46
                  December 31, 2006              $0.61             $0.46

                  March 31, 2007                 $0.69             $.045

                  June 30, 2007                  $0.84             $0.58
                  September 30, 2007             $0.94             $0.70

HOLDERS

         As of September 30, 2007, there were over 775 holders of record of our
common stock outstanding. Our transfer agent is Jersey Transfer & Trust Company,
Inc., Post Office Box 36, Verona, New Jersey 07044.

         No prediction can be made as to the effect, if any, that future sales
of shares of common stock or the availability of common stock for future sale
will have on the market price of the common stock prevailing from time-to-time.
Sales of substantial amounts of common stock on the public market could
adversely affect the prevailing market price of the common stock.

DIVIDENDS

         We have not paid a cash dividend on the common stock since our
acquisition of FPA. The payment of dividends may be made at the discretion of
our board of directors and will depend upon, among other things, our operations,
our capital requirements and our overall financial condition. As of the date of
this prospectus, we have no intention to declare dividends.





                                       10

A SPECIAL NOTE ABOUT PENNY STOCK RULES

         Our common stock is covered by an SEC rule that imposes additional
sales practice requirements on broker-dealers who sell such securities to
persons other than established customers and accredited investors, which are
generally institutions with assets in excess of $5,000,000, or individuals with
net worth in excess of $1,000,000 or annual income exceeding $200,000 or
$300,000 jointly with their spouse. For transactions covered by the rule, the
broker-dealer must make a special suitability determination for the purchaser
and transaction prior to the sale. Consequently, the rule may affect the ability
of broker-dealers to sell our securities, and also may affect the ability of
purchasers of our stock to sell their shares in the secondary market. It may
also cause less broker- dealers to be willing to make a market in our common
stock, and it may affect the level of news coverage we receive.

                                 USE OF PROCEEDS

         We will not receive any proceeds from the sale of our common stock by
the selling shareholders. However, we may receive up to $11,166,883.80 of
proceeds from the options and warrants exercisable to acquire the shares of
common stock we are registering under this prospectus. Any proceeds from the
exercise of options and warrants will be used for working capital.







































                                       11


                MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
                        CONDITION AND PLAN OF OPERATIONS

General

         Management's discussion and analysis contains various forward-looking
statements. These statements consist of any statement other than a recitation of
historical fact and can be identified by the use of forward-looking terminology
such as "may," "expect," "anticipate," "estimate" or "continue" or use of
negative or other variations or comparable terminology.

         We caution that these statements are further qualified by important
factors that could cause actual results to differ materially from those
contained in the forward-looking statements, that these forward-looking
statements are necessarily speculative, and there are certain risks and
uncertainties that could cause actual events or results to differ materially
from those referred to in such forward-looking statements.

Overview

         The Company has developed and patented the Voraxial Separator; a
proprietary technology that efficiently separates large volumes of
liquid/liquid, liquid/solids or liquid/liquid/solids with distinct specific
gravities. We have had limited sales and have shipped units of the Voraxial
Separator on a trial and rental basis to a number of different companies that
include a wide range of industrial applications, including produced water
applications for the oil industry (both offshore oil rigs and onland production
facilities), liquid/liquid and liquid/solid applications for the food processing
industry and the uranium industry. We have installed several Voraxial
Separators to date including units to the Alaska Department of Environmental
Conservation, the US Navy and to a leading uranium producing company in Canada
for oil/water separation. During 2006, we sold a Voraxial 4000 Separator to
ConocoPhillips for produced water separation. The Company is presently marketing
the developing Voraxial Separator as a potential solution for various
applications and markets including oil-water separation and oil exploration and
production.

RESULTS OF OPERATIONS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 AND 2006:

REVENUE

Our revenues increased 38% to $286,676 for the nine months ended September 30,
2007 as compared to $208,425 for the nine months ended September 30, 2006. The
increase in revenue was due to the sales of Voraxial(R) Separator equipment. The
Company continues to focus on its sales and marketing program for the
Voraxial(R) Separator, specifically in the oil exploration and production
market. Interest in the Voraxial Separator has increased significantly in the
past several quarters, as such, Management believes such efforts will continue
to result in additional clients and increasing revenues in 2008.

RESEARCH AND DEVELOPMENT EXPENSES

Research and Development expenses increased by 9% to $305,327 for the nine
months ended September 30, 2007, as compared to $281,124 for the previous nine
months ended September 30, 2006. The Company has finalized the development of
the Voraxial(R) Separator and has begun the sales and marketing of the product.
However, we continue to seek improvements to the product, specifically within
the oil industry.

                                       12

GENERAL AND ADMINISTRATIVE EXPENSES

General and Administrative expenses increased by 222% to $1,420,730 for the nine
months ended September 30, 2007 up from $441,257 for the nine months ended
September 30, 2006. The increase was primarily due to non cash expenses relating
to the issuance and re-pricing of options to employees and consultants in the
first quarter.

YEAR ENDED DECEMBER 31, 2006 COMPARED TO YEAR ENDED DECEMBER 31, 2005

REVENUE

         We continued to focus our efforts and resources to the manufacturing,
assembling, marketing and selling of the Voraxial(R) Separator. Revenues
increased 142% to $310,376 for year ended December 31, 2006 as compared to
$128,070 for the year ended December 31, 2005. The increase is a result of a
sale of the Voraxial Separator and in-house testing and rental shipments to
customers interested in utilizing the Voraxial Separator. Management believes
the interest for the Voraxial Separator for liquid/liquid, liquid/solid and
liquid/liquid/solid separation is increasing from a variety of industries. We
believe we have increased the exposure and awareness of the Voraxial Separator
through our marketing programs and expect to increase revenues from the sale and
lease of the Voraxial Separator in 2006.

COSTS AND EXPENSES

         Costs and expenses decreased by 15% or $172,617 to $1,014,156 for the
year ended December 31, 2006 as compared to $1,186,773 for the year ended
December 31, 2005. The decrease is due to a consolidation of activities
resulting in decreases in general and administrative expenses and decreases in
research and development during the year ended December 31, 2006. Research and
development was primarily due to activities in the oil industry.

GENERAL AND ADMINISTRATIVE EXPENSES

         General and Administrative expenses decreased by 7.5% or $34,024 to
$421,975 for the year ended December 31, 2006 from $455,999 for the year ended
December 31, 2005. The expense remain fairly constant as the Company's focus is
centered on the marketing of the Voraxial(R) Separator.

RESEARCH AND DEVELOPMENT EXPENSES

         Research and Development expenses decreased 19% or $138,592 to $592,181
for the year ended December 31, 2006 from $730,774 for the year ended December
31, 2005. This decrease was due to the reallocations of resources toward our
sales and marketing activities associated with entering into the produced water
segment of the oil industry.

LIQUIDITY AND CAPITAL RESOURCES

Cash at September 30, 2007 was $250,140. Working capital at September 30, 2007
was $109,026 as compared to a working capital deficit at December 31, 2006 of
$1,822.

At September 30, 2007 the Company had an accumulated deficit of $8,272,163. We
anticipate generating positive cash flow from the Voraxial(R) Separator by the
end of 2008. To the extent such revenues and corresponding cash flows do not
materialize, we will continue to require infusion of capital to sustain our
operations. We cannot be assured that we will generate revenues or that the
level of any future revenues will be self-sustaining. Furthermore, we cannot
                                       13

provide any assurances that required capital will be obtained or that terms of
such required capital may be acceptable to us.

The Company has funded working capital requirements and intends to fund current
working capital requirements through third party financing, including the
private placement of securities. However, the Company cannot provide any
assurances that it will be able to obtain adequate financing. If the Company is
unable to obtain adequate financing, it may reduce its operating activities
until sufficient funding is secured or revenues are generated to support
operating activities.

The Company has expanded its sales and marketing efforts for produced water
separation in the oil exploration and production market. During the nine months
ended September 30, 2007 the Company deployed several units of the Voraxial 4000
Separators and Voraxial 2000 Separators for the oil exploration and production
industry. Although the Company is focusing its efforts in the produced water
market, it has deployed units within the oil industry for Deckwater Treatment,
under-balanced drilling, refinery applications and liquid/solid separation. The
Company also installed a Voraxial 2000 Offshore Deck Water Drainage System on a
Transocean Inc. semi-submersible rig Sedco 702. The system will be utilized to
handle and separate contaminated drill floor run-off water containing solids and
drilling fluids on their offshore rig.

During the nine months ended September 30, 2007, the Company received $468,000
from five accredited investors, including institutions, that purchased an
aggregate of 780,000 shares of the Company's restricted common stock at $0.60
per share. Such proceeds will be used to fund working capital requirements.
Subsequent to the nine month period ended September 30, 2007 the Company
received an additional $150,000 from an accredited investor in consideration of
250,000 shares of restricted common stock of the Company. The issuance was
exempt from registration under Section 4(2) of the Securities Act. We believe
current funding will satisfy our working capital needs for the next 6 months, as
our current monthly cash burn rate is approximately $70,000 per month.
Historically the Company has funded working capital requirements under private
offerings facilitated by its management and the Company intends to continue to
fund current working capital requirements through such private placements of
securities. However, the Company cannot provide any assurances that it will be
able to obtain adequate financing. If the Company is unable to obtain adequate
financing, it may reduce its operating activities until sufficient funding is
secured or revenues are generated to support operating activities.

CONTINUING LOSSES

         We may be unable to continue as a going concern, given our limited
operations and revenues and our significant losses to date. Consequently, our
working capital may not be sufficient and our operating costs may exceed those
experienced in our prior years. In light of these recent developments, we may be
unable to continue as a going concern.

         The Company has experienced net losses, has a working capital deficit
and sustained cash outflows from operating activities and had to raise capital
to sustain operations. There is no assurance that the Company's developmental
and marketing efforts will be successful, that the Company will ever have
commercially accepted products, or that the Company will achieve significant
revenues. If the Company is unable to successfully commercialize its Voraxial
Separator, it is unlikely that the Company could continue its business. The
Company will continue to require the infusion of capital until operations become
profitable. During 2007, the Company anticipates seeking additional capital,
increasing sales of the Voraxial Separator and continuing to restrict expenses.
However, substantial doubt exists about the ability of the Company to continue
as a going concern.
                                       14

RECENT ACCOUNTING PRONOUNCEMENTS

         In June 2002, the FASB issued SFAS No. 146, "Accounting for Costs
Associated with Exit or Disposal Activities." The Company's adoption of SFAS No.
146 on January 1, 2003 did not have any material effect on the financial
statements of the Company.

         In December 2003, the FASB issued Interpretation No. 46R,
"Consolidation of Variable Interest Entities" in an effort to expand upon and
strengthen existing accounting guidance that addresses when a company should
include in its financial statements the assets, liabilities and activities of
variable interest entities, including special-purpose entities or off-balance
sheet structures. The consolidation requirements of FIN No. 46R have a variety
of implementation dates. The Company believes the impact of FIN No. 46R on its
financial position and results of operations will not be material, but the
Company will continue to evaluate the impact of FIN No. 46R during the first
quarter of 2004.

         In May 2003, the FASB issued SFAS No. 150, "Accounting for Certain
Financial Instruments with Characteristics of both Liabilities and Equity." This
statement affects the issuer's accounting for three types of freestanding
financial statements: mandatorily redeemable shares, put and forward purchase
contracts that require the issuer to buy back some of its shares in exchange for
cash or other assets, and certain obligations that can be settled in shares.
This statement is effective for all financial instruments entered into or
modified after May 31, 2003, and otherwise effective at the beginning of the
first interim period beginning after June 15, 2003. The impact of adopting FASB
No. 150 was not material to the Company's financial position and results of
operations.

         In December 2003, the Securities and Exchange Commission (SEC),
published Staff Accounting Bulletin (SAB) No. 104, "Revenue Recognition." This
SAB updates portions of the Securities and Exchange Commission (SEC) staff's
interpretive guidance provided in SAB 101 and included in Topic 13 of the
Codification of Staff Accounting Bulletins. SAB 104 deletes interpretative
material no longer necessary, and conforms the interpretive material retained,
because of pronouncements issued by the FASB's Emerging Issues Task Force (EITF)
on various revenue recognition topics, including EITF 00-21, "Revenue
Arrangements with Multiple Deliverables." SAB No. 104 also incorporates into the
SAB Codification certain sections of the SEC staff's "Revenue Recognition in
Financial Statements - Frequently Asked Questions and Answers." SAB No. 104 does
not have a material impact on the Company's financial position and results of
operations since the Company's revenue recognition practices previously
conformed to the interpretations codified by SAB No. 104.

         Management does not expect these statements to have a material impact
on the consolidated financial statements.













                                      15

                                    BUSINESS

OUR HISTORY

         Enviro Voraxial Technology, Inc. was incorporated in Idaho on October
19, 1964, under the name Idaho Silver, Inc. From our inception through 1994, we
were engaged in acquiring mining claims and exploring for silver and lead in
Idaho. In May of 1996, we entered into an agreement and plan of reorganization
with a privately held Florida corporation, Florida Precision Aerospace, Inc.
("FPA"), and its shareholders. FPA was incorporated on February 26, 1993. We
exchanged 10,000,000 newly issued post-split shares of our common stock, or
approximately 97% of our shares then issued and outstanding for all of the
issued and outstanding shares of FPA. As a result of this reorganization, the
shareholders of FPA gained control of our company and FPA became our wholly
owned subsidiary. Because FPA's management was more qualified to focus our
business on that of FPA, our officers and directors resigned and were replaced
by FPA's designees. At the close of the transaction, we changed our name to
Enviro Voraxial Technology, Inc.

GENERAL

         We believe we are emerging as a potential leader in the rapidly growing
environmental and industrial separation industries. The Company has developed
and patented the Voraxial(R) Separator; a proprietary technology that
efficiently separates large volumes of liquid/liquid, liquid/solids or
liquid/liquid/solids with distinct specific gravities. Management believes its
high separation quality is achieved in real-time, and in much greater volumes,
with a more compact, cost efficient and energy efficient machine than any
comparable product on the market today. The Voraxial(R) Separator operates
in-line and is scaleable.

         The size and efficiency advantages provided by the Voraxial(R)
Separator to the end-user have provided us with a variety of market
opportunities. We have generated limited revenues to date partially because of
insufficient funds to adequately market our product; however, we have received
inquiries from parties in various industries, including oil exploration and
production.

         We have had limited sales and have shipped units of the Voraxial(R)
Separator on a trial and rental basis to a number of different companies that
include a wide range of industrial applications, including produced water
applications for the oil industry (both offshore oil rigs and onland production
facilities), liquid/liquid and liquid/solid applications for the food processing
industry and the uranium industry. We have installed several Voraxial(R)
Separators to date including units to the Alaska Department of Environmental
Conservation, the US Navy and to a leading uranium producing company in Canada
for oil/water separation. During 2006, we sold a Voraxial(R) 4000 Separator to
ConocoPhillips for produced water separation.

VORAXIAL(R) SEPARATOR

         The Voraxial(R) Separator is a continuous flow turbo machine that
generates a strong centrifugal force, a vortex, capable of separating light and
heavy liquids, such as oil and water, or any other combination of liquids and
solids at extremely high flow rates. As the fluid passes through the machine,
the Voraxial(R) Separator accomplishes this separation through the creation of a
vortex. In liquid/liquid and liquid/solid mixtures, this vortex causes the


                                       16


heavier compounds to gravitate to the outside of the flow and the lighter
elements to move to the center where an inner core is formed. The liquid stream
processed by the machine is divided into separate streams of heavier and lighter
liquids and solids. As a result of this process, separation is achieved.

         The Voraxial(R) Separator is a self-contained, non-clogging device that
can be powered by an electric motor, diesel engine or by hydraulic power
generation. Further, the Voraxial(R) Separator's scalability allows it to be
utilized in a variety of industries and to process various amounts of liquid.
The following are the various sizes and the corresponding capacity range:

PRODUCT AND CAPACITY RANGE

                            Model            Diameter         Capacity Range
                           Number              Size         Gallons Per Minute
                           ------           ----------      ------------------
                      Voraxial(R)1000         1 inch               3 - 5
                      Voraxial(R)2000         2 inches            25 - 80
                      Voraxial(R)4000         4 inches           250 - 600
                      Voraxial(R)8000         8 inches         2,000 - 6,000

         We currently maintain an inventory of various models of the Voraxial(R)
Separator. During fiscal year 2006, we further tested, demonstrated and
delivered on a trial and rental basis the Voraxial(R) Separator units to
companies within various industries including energy production, wastewater,
manufacturing and mining. During 2006 the Company provided Voraxial(R)
Separators to several firms and is engaged in discussions to deliver additional
Voraxial(R) Separators on an income-producing basis.

         Management believes that our Voraxial(R) Separator offers substantial
applications on a cost-effective basis, including: oil exploration & production,
oil remediation services, municipal wastewater treatment, bilge water
purification, food processing waste treatment and numerous other industrial
production and environmental remediation processes. We also believe that the
quality of the water separated from the contaminant is good enough to recycle
back into the process stream (back into the plant) or discharge to the
environment. As clean water becomes less available to the ever-increasing world
population, this technology may become more valuable.

VORAXIAL(R) SEPARATOR MARKET

         The need for effective and cost efficient wastewater treatment and
separation technology is global in scale. Moreover, virtually every industry
requires some type of separation process either during the manufacturing
process, prior to treatment or discharge of wastewater into the environment, for
general clean up, or emergency response capability. Separation processes,
however, are largely unknown to the average consumer. These processes are deeply
integrated in almost all industrial processes from oil to wastewater to
manufacturing. Management believes that the Voraxial(R) technology has
applications in most, if not all major separation industries. The unique
characteristics of the Voraxial(R) allow it to be utilized either as a
stand-alone unit or within an existing system to provide a more efficient and
cost effective way to handle the separation needs of the customer.







                                       17

         We believe that we are the only front-end solution for the separation
industry that can offer increased productivity while reducing the physical space
and energy required to operate the unit. These advantages translate into the
potential for substantial operating cost efficiencies that may increase the
profitability of the solution's end user.

         If environmental regulations, both domestically and internationally,
become more stringent, companies may be required to more effectively treat their
wastewater prior to discharge. We believe this offers a good opportunity for the
Company as the Voraxial(R) Separator can be utilized in most separation
applications to significantly increase the efficiency of the separation
processes while simultaneously reduce the cost to the end-user.

         Management believes that the oil industry, and more specifically the
produced water market within this industry, represents a good opportunity for
significant sales growth for the Voraxial Separator. The produced water market
is worldwide and the need for effective produced water (oil/water) separation is
a major issue for both offshore and land-based oil production facilities. The
ability to efficiently separate produced water waste streams (oil and water) has
enormous economical and environmental consequences for the oil production
industry. Produced water comprises over 98% of the total waste volume generated
by the oil and gas industry, making it the largest volume waste stream
associated with oil and gas production.

         Oil reservoirs frequently contain large volumes of water and as oil
wells mature (the oil field becomes depleted), the amount of produced water
increases. According to American Petroleum Institute (API), about 18 billion
barrels of produced water was generated by US onshore operations in 1995.
Worldwide, the total amount of produced water generated in 1999, according to
Khatib and Verbeek, was approximately 77 billion barrels. Produced water volumes
will continue to increase as oil wells mature.

         We believe that the necessity to process and efficiently separate high
volumes of liquids coupled with the more stringent environmental regulations
worldwide will continue to increase the demand for the Voraxial(R) Separator.
The Voraxial(R) provides efficient separation while decreasing the amount of
space, energy and weight to conduct the separation. In addition to oil
separation, the Voraxial can also perform solid (sand and grit) extraction,
which prevents production damage by increasing the life of the well.

INVENTORY

         Other than our Voraxial(R) Separators, we maintain no inventory of
finished parts until we receive a customer order. We currently have various
models of the Voraxial(R) Separator in inventory, which includes certain models
located at third party facilities on a trial basis.

COMPETITION

         We are subject to competition from a number of companies who have
greater experience, research abilities, engineering capability and financial
resources than we have. Although we believe our Voraxial(R) Separator offers
applications which accomplish better or similar results on a more cost-effective
basis than existing products, other products have, in some instances, attained
greater market and regulatory acceptance. These competitors include, but are not
limited to Westfalia and AlfaLaval.





                                       18

MARKETING

         The Company's products and services are marketed through our existing
staff and consultants. We have presented the Voraxial(R) Separator at several
prominent trade shows in the past fiscal year. In February 2005, we demonstrated
our Voraxial(R) Separator in Shell Technology Ventures (STV) trade booth, a
division of Royal Dutch/Shell Group (NYSE:RD), at the 22nd SPE/IADC Drilling
Conference and Exhibition in Amsterdam, The Netherlands. Our objective in
attending the conference was to increase awareness and strengthen relationships
between STV and members of the SPE/IADC while providing us with the exposure
and, hence, the business opportunities with potential customers. The specific
applications addressed with our separation technology at the SPE/IADC Drilling
Conference were the treatment of produced water and the separation of oil and
water at the various steps in the oil production process; namely, extraction,
transportation and initial refining of crude oil.

         The Company believes it has received a great response from potential
clients and manufacturers representatives from the above-mentioned tradeshows
and is still pursuing some of these opportunities. We anticipate presenting the
Voraxial(R) Separator at additional tradeshows in 2007.

SOURCES AND AVAILABILITY OF RAW MATERIALS

         The Voraxial(R) Separator is currently manufactured and assembled at
our Fort Lauderdale, Florida facilities.

         The materials needed to manufacture our Voraxial(R) Separator have been
provided by Baldor Electric Co., Hughes Supply Inc. and SKF USA Inc., among
other suppliers. We have no written agreements with suppliers. We do not
anticipate any shortage of component parts.

INTELLECTUAL PROPERTY

         We currently hold several patents pertaining to the Voraxial(R)
Separator and are continually working on developing other patents. The Company
owns United States Patent #6,248,231, #5,904,840 and #5,084,189. The latest
patent, Patent #6,248,231 was registered in 2001 for Apparatus with Voraxial(R)
Separator and Analyzer. Patent #5,904,840 is for Apparatus for Accurate
Centrifugal Separation of Miscible and Immiscible Media, which is for technology
invented by our president and sole director, Alberto DiBella, and registered in
1999. The other is for the Method and Apparatus for Separating Fluids having
Different Specific Gravities. This is for technology invented by Harvey Richter
and registered in 1992 to Richter Systems, Inc. In 1996, we acquired assets,
including this patent from Richter Systems, Inc. The method and apparatus for
each of these is applied in our Voraxial(R) Separator. The Company has filed for
additional patents pertaining to the Voraxial(R) Separator. These patents are
still pending.

         In addition, on December 16, 2003, we received trademark protection for
the word "Voraxial".











                                       19

PRODUCT LIABILITY

         Our business exposes us to possible claims of personal injury, death or
property damage, which may result from the failure, or malfunction of any
component or subassembly manufactured or assembled by us. We have product
liability insurance up to $1,000,000 per incident. However, any product
liability claim made against us may have a material adverse effect on our
business, financial condition or results of operations in light of our poor
financial condition, losses and limited revenues.

         We obtained directors and officers, and general insurance coverage in
2004. We obtained product liability insurance in 2005.

RESEARCH AND DEVELOPMENT

         In our past two fiscal years, we have spent approximately $1,323,000 on
product research and development. The Company has finalized the development of
the Voraxial(R) Separator. Although we will continually work on advancing the
technology and applications whereby the technology can be used, we do not
anticipate devoting a significant portion of any future funds to this area of
the business.

EMPLOYEES

         We have 4 employees. All of our employees work full-time. None of our
employees are members of a union. We believe that our relationship with our
employees is favorable. We intend to add additional employees in the upcoming
year, including managers, sales representatives and engineers.

PROPERTIES

         During September 2004, the Company entered into a three (3) year lease
for an office and manufacturing facility located at 821 NW 57th Place, Fort
Lauderdale, FL 33309. The lease is approximately $5,640 per month for the
initial two years of the lease and approximately $5,700 per month for the third
year of the lease. The Company has the option to renew the lease at the end of
the three-year term. We believe this facility is adequate to maintain our
operations for the next 24 months.
























                                       20

                                   MANAGEMENT

Directors and executive officers

         The following sets forth the names and ages of our officers and
directors. Our directors are elected annually by our shareholders, and the
officers are appointed annually by our board of directors.

           Name                 Age        Position
           ----                 ---        --------
           Alberto DiBella      74         President and Director
           John A. DiBella      35         Executive Vice President and Director

         ALBERTO DIBELLA is a graduate of the Florence Technical Institute,
Italy, where he obtained a degree in mechanical engineering in 1952. After
immigrating to the United States in 1962, Mr. DiBella worked in New Jersey for a
major tool manufacturer. From 1988 to 1993, he was the President of E.T.P., Inc,
a machining business, where he was responsible for day-to-day operations of the
company. In 1993, he relocated to Florida and founded FPA, our wholly owned
subsidiary. Since our inception he has worked in the day-to-day operations of
FPA. He has been our president and chairman since June 1996 and president and
chairman of our subsidiary, FPA, since its organization in February 1993.

         JOHN A. DIBELLA has served as an employee of our Company since January
2002. In August 2006 the Company expanded its board of directors to two members.
John DiBella was appointed by the board to fill the vacancy created by the
additional board seat. From 2000 through January 2002 Mr. DiBella provided
consulting services to our Company. Mr. DiBella currently serves as the
Company's Vice President of Business Development. Mr. DiBella co-founded and
served as President of PBCM, a financial management company located in New
Jersey from 1997 to 1999. While at PBCM, Mr. DiBella was involved in various
consulting services regarding the development of publicly traded companies,
including establishing a management team, negotiating partnerships, licensing
agreements and investigating merger and acquisition opportunities. Prior to
co-founding PBCM, Mr. DiBella served as a Securities Analyst in the Equities and
Derivatives Department for Donaldson, Lufkin and Jenrette, a NYSE member firm.
Mr. DiBella holds a Bachelor of Science Degree in Finance and Economics from
Rutgers University. Mr. DiBella is the nephew of Alberto DiBella.

COMMITTEES

         To date, we have not established an audit committee. Due to our
financial position, we have been unable to attract qualified independent
directors to serve on our board. Our board of directors, solely consisting of
Alberto DiBella, reviews the professional services provided by our independent
auditors, the independence of our auditors from our management, our annual
financial statements and our system of internal accounting controls. Mr. DiBella
is not considered a "financial expert."

         We have not established a compensation committee or nominating
committee.










                                       21

ADVISORY COMMITTEE

         We have established an Advisory Committee. The purpose of the Advisory
Committee is to provide business advice and recommendations to management of the
Company. The Advisory Committee consists of J. John Combs, Barry Gafner, Kevin
Mulshine and Henry Schlesinger. These individuals serve for a 2-year term.

         On February 18, 2004, we issued options to purchase an aggregate of
30,000 shares of our common stock exercisable at $0.71 per share to three of the
individuals as consideration for joining our advisory committee. The options are
exercisable until February 18, 2008.

INDEMNIFICATION

         The Idaho Statutes permit the indemnification of directors, employees,
officers and agents of Idaho corporations. Our Articles of Incorporation and
Bylaws provide that we shall indemnify its directors and officers to the fullest
extent permitted by the Idaho Statutes.

         The provisions of the Idaho Statutes that authorize indemnification do
not eliminate the duty of care of a director, and in appropriate circumstances
equitable remedies such as injunctive or other forms of non-monetary relief will
remain available under Idaho. In addition, each director will continue to be
subject to liability for (a) violations of criminal laws, unless the director
had reasonable cause to believe his conduct was lawful or had no reasonable
cause to believe his conduct was unlawful, (b) deriving an improper personal
benefit from a transaction, (c) voting for or assenting to an unlawful
distribution and (d) willful misconduct or conscious disregard for our best
interests in a proceeding by or in the right of a shareholder. The statute does
not affect a director's responsibilities under any other law, such as the Idaho
securities laws.

         The effect of the foregoing is to require us to indemnify our officers
and directors for any claim arising against such persons in their official
capacities if such person acted in good faith and in a manner that he reasonably
believed to be in or not opposed to the best interests of the corporation and,
with respect to any criminal action or proceeding, had no reasonable cause to
believe his conduct was unlawful.

         Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to our directors, officers or persons in control
pursuant to the foregoing provisions, we have been informed that in the opinion
of the Securities and Exchange Commission, such indemnification is against
public policy as expressed in the act and is therefore unenforceable.

EXECUTIVE COMPENSATION

           The table below sets forth compensation for the past two years
awarded to, earned by or paid to our chief executive officer and each executive
officer whose compensation exceeded $100,000 for the year ended December 31,
2006.
                                       22



                                      Summary Compensation Table

---------------------------------------------------------------------------------------------------------------------------
                                                                                       Change in
                                                                                        Pension
                                                                                       Value and
                                                                         Non-Equity   Nonqualified
                                                                          Incentive    Deferred
                                                         Stock  Option      Plan      Compensation  All Other
                                       Salary   Bonus   Awards  Awards   Compensation  Earnings    Compensation  Total
Name and Principal Position  Year       ($)      ($)      ($)     ($)        ($)          ($)          ($)        ($)
--------------------------------------------------------------------------------------------------------------------------
                                                                                                       
Alberto DiBella,             2006   $175,000(1)   --      --      --         --           --           --       $175,000
CEO and Principal            2005   $165,000(2)   --      --      --         --           --           --       $165,000
  Financial Officer
--------------------------------------------------------------------------------------------------------------------------
John A. DiBella,             2006   $175,000(3)   --      --      --         --           --           --       $175,000
  Executive Vice President   2005   $150,000(4)   --      --      --         --           --           --       $150,000
--------------------------------------------------------------------------------------------------------------------------

(1)      Of these amounts, only $74,785 has been paid out for the year ended
         December 31, 2006. Unpaid balance has been included in accrued
         expenses.
(2)      Of these amounts, only $43,000 was paid out for the year ended December
         31, 2005. Unpaid balance has been included in accrued expenses.
(3)      $129,000, has been deferred in 2006.
(4)      $145,000 has been deferred.




























                                       23



                         2006 Outstanding Equity Awards At Fiscal Year-End Table

----------------------------------------------------------------------------------------------------------------------
                                       Option Awards                                    Stock Awards
----------------------------------------------------------------------------------------------------------------------
                                                                                                             Equity
                                                                                                             Incentive
                                                                                                  Equity     Plan
                                                                                                  Incentive  Awards:
                                                                                                  Plan       Market
                                                                                                  Awards:    or
                                            Equity                                                Number     Payout
                                            Incentive                                             of         Value of
                                            Plan                            Number     Market     Unearned   Unearned
                  Number of   Number of     Awards:                         of         Value of   Shares,    Shares,
                  Securities  Securities    Number of                       Shares     Shares     Units or   Units or
                  Underlying  Underlying    Securities                      or Units   or Units   Other      Other
                  Unexercised Unexercised   Underlying                      of Stock   of Stock   rights     rights
                  Options     Options       Unexercised  Option             That       That       That       That
                     (#)          (#)       Unearned     Exercise  Option   Have Not   Have Not   Have Not   Have Not
------------------------------------------- Options      Price   Expiration Vested     Vested     Vested     Vested
      Name        Exercisable Unexercisable   (#)         ($)      Date       (#)        ($)        (#)        ($)
----------------------------------------------------------------------------------------------------------------------
                                                          
Alberto DiBella      110,000      --           --       $0.60      2009          --         --         --         --
                     110,000      --           --       $1.00      2009          --         --         --         --
----------------------------------------------------------------------------------------------------------------------
John DiBella       2,000,000      --           --       $0.15      2007          --         --         --         --
                     516,666      --           --       $0.60      2009          --         --         --         --
                     516,666      --           --       $1.00      2009          --         --         --         --
----------------------------------------------------------------------------------------------------------------------

2006 Option and Stock Grants

         None.

EMPLOYMENT AGREEMENTS

         Neither of our executive officers has a written employment agreement
with the Company. However the Company intends to enter into an employment
agreement with John A. DiBella during 2007. We currently pay the CEO and
Executive Vice President approximately $15,000 per month which a high percentage
is accrued.

DIRECTOR COMPENSATION

         Directors are not compensated by our Company.

                              CERTAIN TRANSACTIONS

         During the fourth quarter of 2005, John A. DiBella received 1,000,000
shares of common stock from Alberto DiBella.

         During the fourth quarter of 2005 Alberto DiBella entered into
agreements with Robert Weinberg and Peter Chiappetta related to personal
advances made by Mr. Weinberg and Mr. Chiappetta to Mr. DiBella. Such advances
were not related to the Company. In full satisfaction of the advances, Mr.
DiBella transferred an aggregate of 5,000,000 shares of the Company's common
stock to Mr. Weinberg and Mr. Chiappetta.
                                       24

         SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

         As of December 31, 2006, there were 21,992,235 shares of our common
stock outstanding. The table below sets forth information with respect to the
beneficial ownership of our securities as of December 31, 2006 by:

         1) each person known by us to be the beneficial owner of five percent
            or more of our outstanding securities, and

         2) executive officers and directors, individually and as a group.

         Unless otherwise indicated, we believe that the beneficial owner has
sole voting and investment power over such shares.

Name and Address of                      Number of Shares       Percentage of
   Beneficial Owner                     Beneficially Owned       Ownership
   ----------------                     ------------------       ---------

Alberto DiBella                             3,266,666(1)            16.6%
3500 Bayview Drive
Fort Lauderdale, FL  33308

John A. DiBella                             4,033,333(2)            17.9%
821 N.W. 57th Place
Fort Lauderdale, FL  33309

Robert Weinberg                             2,000,000(3)            10.3%
11338 Clover Leaf Circle
Boca Raton, FL 33428

Peter Chiappetta                            3,000,000(3)            15.4%
2299 NW 62nd Drive
Boca Raton, FL 33487

All officers and directors                  7,299,999               34.5%
as a group (2 persons)

(1)    Alberto DiBella's beneficial share ownership includes 10,000 shares of
       common stock owned by his wife. Also includes 110,000 shares of common
       stock underlying options exercisable at $0.60 per share and 110,000
       shares of common stock underlying options exercisable at $1.00 per share.

(2)    Includes 2,000,000 shares of common stock underlying options exercisable
       at $0.15 per share, 516,666 shares of common stock underlying options
       exercisable at $0.60 per share and 516,666 shares of common stock
       underlying options exercisable at $1.00 per share. Excludes shares, which
       Mr. DiBella holds voting control, but does not hold any power to dispose
       of such shares. See footnote 3.

(3)    Voting rights of said shares were granted to John A. DiBella until such
       time the percentage ownership is less than 3% of the Company.










                                       25

                            DESCRIPTION OF SECURITIES

         As of January 31, 2007, we had authorized 42,750,000 shares of par
value $0.001 common stock, with 21,992,235 shares issued and outstanding.
Additionally, we have authorized 7,250,000 shares of preferred stock, with no
shares issued and outstanding.

COMMON STOCK

         The holders of common stock are entitled to one vote for each share
held of record on all matters to be voted on by shareholders. There is no
cumulative voting with respect to the election of directors, with the result
that the holders of more than 50% of the shares voted for the election of
directors can elect all of the directors. The holders of common stock are
entitled to receive dividends when, as and if declared by the board of directors
out of funds legally available therefor. In the event of our liquidation,
dissolution or winding up, the holders of common stock are entitled to share
ratably in all assets remaining available for distribution to them after payment
of liabilities and after provision has been made for each class of stock, if
any, having preference over the common stock. Holders of shares of common stock,
as such, have no conversion, preemptive or other subscription rights, and there
are no redemption provisions applicable to common stock. All of the outstanding
shares of common stock are, and the shares of common stock offered hereby, will
be duly authorized, validly issued, fully paid and nonassessable.

PREFERRED STOCK

         We are authorized to issue shares of preferred stock with such
designation, rights and preferences as may be determined from time to time by
the board of directors. Accordingly, the board of directors is empowered,
without shareholder approval, to issue preferred stock with dividend,
liquidation, conversion, voting or other rights that could adversely affect the
voting power or other rights of the holders of the common stock. In the event of
issuance, the preferred stock could be utilized, under certain circumstances, as
a method of discouraging, delaying or preventing a change in control. As of the
date of this Prospectus we have no outstanding shares of preferred stock.

WARRANTS

         As of the date of this prospectus, we had outstanding warrants to
purchase 5,438,698 shares of our common stock exercisable at the following
prices:

      265,250 shares are underlying warrants exercisable at $0.75 per share,
      4,213,582 shares are underlying warrants exercisable at $1.00 per share,
      516,666 shares are underlying warrants exercisable at $1.25 per share,
      100,000 shares are underlying warrants exercisable at $3.00 per share,
      100,000 shares are underlying warrants exercisable at $4.00 per share,
      121,600 shares are underlying warrants exercisable at $6.00 per share, and
      121,600 shares are underlying warrants exercisable at $9.00 per share.

         As of the date of this prospectus we had outstanding options to
purchase 4,104,666 shares of our common stock exercisable at the following
prices:






                                       26

      2,000,000 shares are underlying options exercisable at $0.15 per share,
      45,000 shares are underlying options exercisable at $0.30 per share,
      697,333 shares are underlying options exercisable at $0.60 per share,
      30,000 shares are underlying options exercisable at $0.71 per share,
      200,000 shares are underlying options exercisable at $0.77 per share,
      150,000 shares are underlying options exercisable at $0.80 per share,
      225,000 shares are underlying options exercisable at $0.80 per share, and
      757,333 shares are underlying options exercisable at $1.00 per share.

      The warrants and options expire on various dates from February, 2007 to
August, 2011. The warrants may be called or repurchased at $0.001 per underlying
share of common stock provided the closing bid price for the Company's Common
Stock is at or above $2.00 per share for twenty consecutive trading days within
30 days of the Company's written notice of the Company's intention to call this
warrant. In the event this warrant has not been exercised by written notice
within 30 days of such notice, the warrant will cease to exist.

TRANSFER AGENT

         The Transfer Agent for our shares of common stock is Jersey Transfer &
Trust, Inc., 201 Bloomfield Ave., Verona, NJ 07044. The telephone number for
Jersey Transfer & Trust, Inc is (973) 239-2712.

                              SELLING SHAREHOLDERS

         This prospectus relates to the registration of 9,543,363 shares of our
common stock underlying certain warrants and options held by various parties
listed below. We will not receive any proceeds from the sale our common stock by
the selling shareholders. However, we may receive up to $11,166,883.80 of
proceeds from the options and warrants exercisable to acquire the shares of
common stock we are registering under this prospectus. Any proceeds from the
exercise of options and warrants will be used for working capital. The selling
shareholders may resell the shares they acquire by means of this prospectus from
time to time in the public market. The costs of registering the shares offered
by the selling shareholders are being paid by us. The selling shareholders will
pay all other costs of the sale of the shares offered by them.

         The following table sets forth the name of the selling shareholders,
the number of common shares that may be offered by the selling shareholders and
the number of common shares to be owned by the selling shareholders after the
offering. The table also assumes that each selling shareholder sells all common
shares listed by its name. The table below sets forth information as of the date
of this prospectus. The percentage calculations for the selling shareholders do
not include any common shares issuable upon the exercise of any currently
outstanding warrants, options or other rights to acquire common shares, other
than those that the selling shareholders beneficially own. Unless otherwise
noted below, the address for the selling shareholder is 821 N.W. 57th Place,
Fort Lauderdale, Florida 33309.













                                       27





                                                 Common Shares            Common Shares        Common Shares
                                                  Owned Prior                Offered            Owned After
                                                  to Offering            in the Offering       the Offering
Name of Shareholder                         Number       Percentage          Number         Number     Percentage
-------------------                         ------       ----------          ------         ------     ----------
                                                                                        
John M. and Gail S. Antonakos, JTWROS        20,000          *              20,000(1)             0        *
1079 Route 523
Flemington, NJ 08822

Glen B. Bagnall                               6,000          *               6,000(1)             0        0
24111 Meridian Rd #117
Grosse, Lle MI 48138

Paul Bendigo                                  4,000          *               4,000(1)             0        0
250 Dickinson Drive
Reading, PA 19605

Thomas W. Bilowus                             2,000          *               2,000(1)             0        0
4553 Lake Ave
Blasdell, NY 14219-1303

Ruth Butler                                 124,000          *              16,000(1)       108,000        *
207 Sharon Pkwy
Lackawanna, NY 14218

Agatino Cintorrino                           72,600          *              38,400(1)(4)     34,200        *
37 W. Main Street
Somerville, NJ 08876

Kenneth G. Conrad                            66,334          *              38,667(1)(4)     27,667        *
2935 Rising Sun Road
Slatington, PA 18080

James Dahme                                  39,334          *              22,667(1)(4)     16,667        0
1237 Yellow Springs Road
Chester Springs, PA 19425

Joseph Di Bella                              70,000          *              35,000(1)(4)     35,000        *
10 Sandy Hill Rd.
Westfield, NJ 07090

Rita DiPalo                                  18,100          *               8,933(1)(4)      9,167        *
1008 Featherbed Lane
Edison, NJ 08820

Paul J. and Linda A. Fischl                   2,000          *               2,000                0        *
760 Point Phillips Road
Bath, PA 18014

Donald Hughes                                 4,000          *               4,000                0        *
2101 Springhouse Road
Broomal, PA 19008

Hal P. Johnson                                6,000          *               6,000                0        *
P.O. Box 2557
West Lawn, PA 19609


                                       28



                                                                                        
Ralph Liloia                                  2,000          *               2,000                0        *
11 Liverpool Ct.
Toms River, NJ 08753

Paul J. Mueller                               6,000          *               6,000                0        *
3045 Van Alstyne
Wyandotte, MI 48192

Joseph E. Mueller                             8,000          *               8,000                0        0
28437 Balmoral
Garden City, MI 48135

Linda Rammage                                10,000          *              10,000                0        0
8112 W Six Mile Rd
Northville, MI 48167

John L. Rowe                                 57,334          *              28,667(1)(4)     22,667        *
356 Magnolia Road
Warminster, PA 18974

Paul J. and Marie Sharga, JTWROS             30,000          *              20,000           10,000        *
1515 Newport Avenue
Northampton, PA 18067

Edward G. Brown and
Janet M. Nickerson                            2,000          *               2,000                0        *
RR 2 Box 2440
Leeds, ME 04263

Arnold J. Solof                               8,000          *               8,000                0        *
1816 Redwood Drive
Vineland, NJ 08361-6750

Jeffrey P. Szackas                            2,000          *               2,000                0        *
23G Greentop Road
Sellersville, PA 18960

Susan V Timmreck                              4,000          *               4,000                0        *
901 Cedar Street
Millville, NJ 08332

Michael & Antoinetta Ulisse                  17,700          *               8,533(1)(2)      9,167        *
17 Lynwood Road
Edison, NJ 08820

Ellen Van Embden                              2,000          *               2,000                0        0
3312 Sherwood Road
Easton, PA 18045

Nathan Van Embden                             4,000          *               4,000                0        0
787 Hogbin Road, P.O. Box 1641
Millville, NJ 08332

Karen Van Embden                              4,000          *               4,000                0        0
807 South Fountain
Wichita, KS 67218

                                       29



                                                                                        
Paul Van Embden                               2,000          *               2,000                0        0
1007 Cedar
Millville, NJ 08332

Laura Van Embden                              4,000          *               4,000                0        *
1007 Cedar Street
Millville, NJ 08332

Julie Van Embden                              4,000          *               4,000                0        *
4132 Garfield Avenue
Pennsauken, NJ 08109

Phillip S. Van Embden                         6,000          *               6,000                0        *
P.O. Box 863
Millville, NJ 08332

Richard Williams                              2,000          *               2,000                0        *
998 Newichawnoe Lane
Bath, PA 18014

Roland W. and Dianne S. Woodall               4,000          *               4,000                0        *
R.D. #3 Box 609C
Charleroi, PA 15022

William Lanzana                              30,000          *              20,000           10,000        *
577 Chestnut Ridge Road
Woodcliff Lake, NJ 07675

Kevin Johnson                               300,000                        200,000(2)       100,000        *
7106 Matthews Rd.
Durham, NC 27712

Joan Rich Baer, Inc. (14)
   Pension Plan & Trust                     330,000          *             140,000(3)(4)          0        *
199 Concord Drive
Madison, CT 06443

RBG Residuary Trust (15)                    950,000          3.2%          600,000(3)(4)    350,000        *
8 North Rohallion Drive
Rumson, NJ 07760

Richard Goodwyn                             150,000          *             100,000           50,000        *
8 North Rohallion Drive
Rumson, NJ 07760

The Whittier Trust Company (16)             249,999          *             166,666           83,333        *
   of Nevada, Inc.
Trustee of the Haldan
   Grandchildren's Trust
fbo Seth H. Casden
100 West Liberty Street, Suite 890
Reno, NV 89501

                                       30



                                                                                        
The Whittier Trust Company (17)
   of Nevada, Inc.
   Trustee of the Haldan
   Grandchildren's Trust
   fbo Graham S. Casden                     333,333          *             208,333(3)(4)    125,000        *
100 West Liberty Street, Suite 890
Reno, NV 89501

Harrichand Persaud                          333,332          *             166,666(4)       166,000        *
264 Airmont Ave.
Mahwah, NJ 07430

Barbara J. Drew TTEE for the
   Barbara J. Drew Revocable
   Living Trust  (22)                       166,666          *              83,333(4)        83,333        *
302 Carl Lane
Capitola, CA 95010

Robert Agriogianis                           41,666          *              41,666(4)             0        *
16 Harvale Drive
Florham Park, NJ 07932

Michael H. Lambert                           16,667          *              16,667(4)             0        *
2020 Pintail Drive
Longmont, CO 80504

Richard Zimmer                               41,667          *              41,667(4)             0        *
136 Locktown-Flemington Road
Flemington, NJ 08822

Dominic Spinosa                              83,332          *              83,332(4)             0        *
1766 Roland Ave.
Wantagh, NY 11793-2856

Peter Maciak                                250,000          *             125,000(4)       125,000        *
125 Krager Road
Binghamton, NY 13904

Keys Family Trust (18)                      100,000          *              50,000(4)        50,000        *
1024 Glorietta
Coronado, CA 92118

William Dorfman                              83,334          *              41,667(4)        41,667        *
Century Park East- Suite 1601
LA, CA 90067

Barry Gafner                                180,000          *              95,000(4)(13)    85,000        *
4560 St. Vrain Road
Longmont, CO, 80503

Donald Cameron Rodee                        333,332          *             166,666(4)       166,666        *
1510 Wilshire Road
Fallbrook, CA 92028

Kevin Mulshine                               80,000 (3)(14)  *              45,000(4)(13)    35,000        *
4097 St. Lucia Street
Boulder, CO 80301

Mustafa Chike-Obi                            83,334          *              41,667(4)        41,667        *
175 Brooklake Road
Florham Park, NJ 07932

                                       31



                                                                                        
James P. Kearney                             83,334          *              41,667(4)        41,667        *
59 Union Hill Road
Madison, NJ 07940

Paul J. Sharga                               16,667          *              16,667(4)             0        *
1515 Newport Ave.
Northampton, PA 18067

John W. & Barbara B. Hemmer                  41,667          *              16,667(4)        25,000        *
88 Meadow Road
Briarcliff Manor, NY 10510

Frank J. DeMicco                            200,000 (5)      *             200,000(5)             0        *
1000 Williams Island Blvd. Ste 3102
Aventura, FL 33160

Kim J. Gloystein                             33,333          *              33,333(6)             0        0
7430 S Indian Lake Drive
Vicksburg, MI 49097

Richard T. Huebner IRA                       80,000          *              80,000(6)             0        0
16318 E. Berry Ave.
Centennial, CO 80015

Steven M. Bathgate IRA                      665,071          2.2%          366,667(6)       298,404        *
6376 E. Tufts Ave.
Englewood, CO 80111

Michael J. Beaudoin                          40,000          *              20,000(6)        20,000        *
2915 Miwall Ct.
Castlerock, CO 80109

David W. Beaudoin                            40,000          *              20,000(6)        20,000        *
21544 Tullman Drive
Parker, CO 80111

John R. Cohagen                              66,666          *              33,333(6)        33,333        *
3939 95th St.
Boulder, CO 80301

John David Kucera IRA                        26,666          *              13,333(6)        13,333        *
6178 S. Alton Way
Greenwood Village, CO 80111

Pamela M. Kelsall IRA                        33,334          *              16,667(6)        16,667        *
6117 E. Princeton Ave.
Englewood, CO 80111

Douglas H. Kelsall IRA                       66,666          *              33,333(6)        33,333        *
6117 E. Princeton Ave.
Englewood, CO 80111

Eugene C. McColley  IRA                      50,000          *              50,000(6)             0        0
3900 Garden Ave.
Greenwood Village, CO 80121

Greg Fulton IRA                              33,334          *              16,667(6)        16,667        *
5520 South Newport Street
Greenwood Village, CO 81111

                                       32



                                                                                        
Ann Fulton IRA                               33,334          *              16,667(6)        16,667        *
5520 South Newport Street
Greenwood Village, CO 81111

Sandra Garnet C/F Colin Garnett              66,666          *              33,333(6)        33,333        *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

Sandra Garnet C/F Aaron Garnett              66,666          *              33,333(6)        33,333        *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

Sandra Garnett C/F Benjamin Garnett          66,666          *              33,333(6)        33,333        *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

Lee E. Schlessman                           266,666          *             133,333(6)       133,333        *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

Rodney Garnett, Lee Schlessman POA           66,666          *              33,333(6)        33,333        *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

Sandra L. Garnett,
   Lee E. Schlessman POA                     66,666          *              33,333(6)        33,333        *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

Gary L. Schlessman
   C/F Margaret Schlessman                   33,334          *              16,667(6)        16,667        *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

Gary Schlessman
   C/F Jennifer Schlessman                   33,334          *              16,667(6)        16,667        *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

Cheryl S. Bennett C/F Eric Bennett           33,334          *              16,667(6)        16,667        *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

Cheryl S. Bennett,
   Lee Schlessman POACO                      66,666          *              33,333(6)        33,333        *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

Cheryl S. Bennett
   C/F Lauren M. Bennett                     33,334          *              16,667(6)        16,667        *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

George Johnson IRA                           40,000          *              40,000(6)             0        0
6 Churchill Dr.
Englewood, CO 80113

                                       33



                                                                                        
Kent J. Lund                                 17,000          *              17,000(6)             0        0
203 S Pontiac St.
Denver, CO 80230

George Irwin Lind III IRA                    66,667          *              66,667(6)             0        0
#2 Drive Lane
Littleton, CO 80123

Steven D. Plissey IRA                        34,000          *              17,000(6)        17,000        *
2225 Witter Gulch
Evergreen, CO 80439

Frederic Duboc IRA                          200,000          *             100,000(6)       100,000        *
5500 Pemberton Drive
Greenwood Village, CO 80121

Keysten Investments Ltd. (19)               333,333          *             333,333(6)             0        0
Suite 5050, Commerce Court West 199 Bay Street
Toronto, ON 5ML-1E2

James Edgar McDonald Revocable
   Living Trust Dated 6/30/95 (20)           60,000          *              30,000(6)        30,000        *
6044 E Briarwood Dr
Centennial, CO 80112

Virginia Stevens McDonald Revocable
   Living Trust Dated 6/30/95 (21)           30,000          *              30,000(6)             0        0
6044 E Briarwood Dr.
Centennial, CO 80112

Robert H. Aukerman                           30,000          *              20,000(6)        10,000        *
6077 S. Cathay Ct.
Aurora, CO 80016

Thomas D. Wolf                               40,000          *              20,000(6)        20,000        0
5751 E Nassau Place
Englewood, CO 80111

Christopher J. Koenigs/
   Jeanne F. Collopy JTWRDS                  34,000          *              17,000(6)        17,000        *
2433 E 7th Ave
Denver, CO 80206

Roger Conan                                 120,000          *              60,000(6)        60,000        *
14 Oaklay Rd
Dublin 6, Ireland

Richard Vernon Wilsey                        68,000          *              34,000(6)        34,000        *
P.O. Box 432
Morrison, CO 80465

David L. Gertz                               68,000          *              34,000(6)        34,000        *
7120 E Orchard Rd, Suite 300
Centennial, CO 80111

Vicki D.E. Barone IRA                        16,000          *              16,000(6)             0        0
7854  S Harrison Cir.
Littleton, CO 80122

                                       34



                                                                                        
Bathgate Capital Partners (22)              530,500          *             530,500(7)             0        0
5350 South Roslyn St., Ste 400
Greenwood Village, CO 80111

John A. DiBella                           4,033,333         17.9%       3,066,666(9)(12)    966,667        3.3%
821 NW 57th Place
Fort Lauderdale, FL 33309

Daniel Samela                                45,000          *              45,000(8)             0        0
4072 Oxbow Dr.
Coconut Creek, FL, 33073

Laura DiBella                               200,000          *             200,000(10)            0        0
3500 Bayview Dr.
Ft. Lauderdale, FL 33301

Dan Leon                                     10,000          *              10,000(11)            0        0
4940 NW 85 Ave
Lauderhill, FL 33351

Alberto DiBella                           3,266,666         11%           220,000(12)     3,046,666       10%
3500 Bayview Dr.
Ft. Lauderdale, FL 33301

J. John Combs                               483,000          *             483,000(12)            0        0
6494 Nelson Rd
Longmont CO 80503

Henry Schlesinger                            10,000          *              10,000(13)            0        0
18802 Pheasant Lane
Tomball, TX 77377

                                                                  Total: 9,543,363

* Denotes ownership of less than 1%. Percentage ownership assumes complete sale
of securities into the open market after exercise of warrants or options. Some
investors have invested on more than 1 occasion. Their total ownership is shown
only once in Column A.

(1)      Includes warrants issued through a private placement conducted in
         February 2000. In the first half of 2000, we raised $364,800 through
         the private placement of our securities. We sold 1,216 units to 34
         accredited investors. Each unit was comprised of one hundred shares of
         restricted common stock and 200 warrants, one hundred exercisable at
         $6.00 and one hundred exercisable at $9.00. A total of 243,200 warrants
         were issued in this Offering, which includes 121,600 warrants
         exercisable at $6.00 and 121,600 warrants exercisable at $9.00. The
         issuances were exempt from registration under Section 4(2) of the
         Securities Act. The investors received information concerning the
         Company and had the opportunity to ask questions concerning the
         viability of the Company. The shares contain legends restricting their
         transferability absent registration or applicable exemption.

(2)      Includes warrants issued through a private offering in April 2001. In
         April 2001, we raised $100,000 through the private placement of our
         securities. We sold 1,000 units containing share of our common stock
         and warrants to one accredited investor. Each unit was comprised of 100
         shares of restricted common stock and 200 common stock purchase
         warrants, of which 100 warrants are exercisable at $3.00 per share and
         100 warrants are exercisable at $4.00 per share. A total of 200,000
         warrants were issued in this Offering, which includes 100,000 warrants
                                       35

         exercisable at $3.00 and 100,000 warrants exercisable at $4.00. The
         issuances were exempt from registration under Section 4(2) of the
         Securities Act. The investors received information concerning the
         Company and had the opportunity to ask questions concerning the
         viability of the Company. The shares contain legends restricting their
         transferability absent registration or applicable exemption.

(3)      Includes warrants issued through a private placement in fiscal year
         2002. During the year ended December 31, 2002, we sold 5.17 units of
         securities at $60,000 per unit in a private placement to 5 investors.
         Each unit consisted of 100,000 shares of common stock, 100,000 warrants
         to purchase 100,000 shares of common stock at an exercise price of
         $1.00 per share and 100,000 warrants to purchase 100,000 shares of
         common stock at an exercise price of $1.25 per share. The warrants
         issued at $1 per share are callable at par value provided the stock
         trades above $1.50 per share for 20 consecutive trading days. The
         warrants issued at $1.25 per share are callable at par value provided
         the stock trades above $2 per share for 20 consecutive trading days.
         Net proceeds received by our Company aggregated $286,000. The warrants
         are exercisable from the date of issuance through December 2007. A
         total of 1,033,332 warrants were issued in this Offering, which
         includes 516,666 warrants exercisable at $1.00 and 516,666 warrants
         exercisable at $1.25. The issuances were exempt from registration under
         Section 4(2) of the Securities Act. The investors received information
         concerning the Company and had the opportunity to ask questions
         concerning the viability of the Company. The shares contain legends
         restricting their transferability absent registration or applicable
         exemption.

(4)      Includes warrants issued through a private placement, which commenced
         in 2003 and was closed in January 2004. Under the private placement we
         sold an aggregate of 8.08 units of securities to 30 investors for
         proceeds of $808,000. Each unit consisted of 166,666 shares of
         restricted common stock at $0.60 per share and 166,666 warrants to
         purchase 166,666 shares of common stock at $1.00 per share. The
         warrants are exercisable for a period of five years from the date of
         closing. The investors received information concerning our company and
         had the opportunity to ask questions to the viability of our company. A
         total of 1,346,665 warrants were issued in this Offering. The issuances
         were exempt from registration under Section 4(2) of the Securities Act.
         The investors received information concerning the Company and had the
         opportunity to ask questions concerning the viability of the Company.
         The shares contain legends restricting their transferability absent
         registration or applicable exemption.

(5)      Effective January 1, 2003, we issued warrants to purchase 300,000
         shares of our common stock exercisable at $1.00 per share to Frank
         DeMicco pursuant to Mr. DeMicco's five-year employment contract with
         our company. Warrants to purchase 100,000 shares vested during year
         ended December 31, 2003 and the remaining warrants vest periodically
         over the term of the agreement. The balance 150,000 warrants were
         cancelled due to the mutual termination of DeMicco's employment
         contract. In January 2005, the Company entered into a one-year
         consulting agreement with Mr. DeMicco for engineering design, marketing
         and sales of Company products and services. Pursuant to this agreement,
         the Company granted 50,000 options to Mr. DeMicco exercisable at $1.00
         per share. These options vest equally in 12 traunches over a period of
         one year commencing in January, 2005 and expire in January 2008. The
         options and warrants issued to Mr. DeMicco were exempt from
         registration under Section 4(2) of the Securities Act. The options and
         warrants contain the appropriate restrictive legend restricting their
                                       36

         transferability absent registration or applicable exemption. Mr.
         DeMicco received information concerning our company and had the
         opportunity to ask questions about the viability of our company.

(6)      Includes warrants issued through a private placement in fiscal year
         2004. From May 2004 through August 2004, the Company sold an aggregate
         of 1,935,000 units of securities to 38 accredited investors for gross
         proceeds of $1,451,250 under the private placement (Schedule D). The
         Company paid Bathgate Capital Partners, a placement agent, a commission
         of 10% of the gross proceeds and a non-accountable expense allowance of
         3% of the gross proceeds and issued the placement agent warrants to
         purchase six shares of common stock (three shares at $0.75 and three
         shares at $1.00) for each 20 units sold in the offering. Each unit
         consisted of one share of restricted common stock at $0.75 per share
         and one warrant to purchase one share of common stock at $1.00 per
         share. The warrants are exercisable for a period of five years from the
         date of closing. A total of 1,935,000 warrants were issued in this
         offering. The issuances were exempt from registration under Section
         4(2) of the Securities Act. The investors received information
         concerning the Company and had the opportunity to ask questions
         concerning the viability of the Company. The shares contain legends
         restricting their transferability absent registration or applicable
         exemption.

(7)      Includes the number of warrants issued to Bathgate Capital Partners as
         commissions for the private placement discussed above. The Company has
         paid Bathgate Capital Partners, a placement agent, a commission of 10%
         of the gross proceeds and a non-accountable expense allowance of 3% of
         the gross proceeds and issued the placement agent warrants to purchase
         six shares of common stock (three shares at $0.75 and three shares at
         $1.00) for each 20 units sold in the offering. Each unit consisted of
         one share of restricted common stock at $0.75 per share and one warrant
         to purchase one share of common stock at $1.00 per share. The warrants
         are exercisable for a period of five years from the date of closing.
         The transactions were exempt from registration under Section 4(2) of
         the Securities Act. Bathgate Capital Partners was deemed accredited.
         The investors received information concerning the Company and had the
         opportunity to ask questions concerning the viability of the Company.
         The shares and warrants contain legends restricting their
         transferability absent registration or applicable exemption. A total of
         530,000 warrants were issued to Bathgate Capital Partners, which
         includes 265,250 warrants exercisable at $0.75 and 265,250 warrants
         exercisable at $1.00.

(8)      During November 2001 we issued options to purchase 45,000 shares of our
         common stock exercisable at $0.30 per share to an individual pursuant
         to an employment agreement with our company. The options vest
         periodically over the term of the agreement. The options issued to the
         employee were exempt from registration under Section 4(2) of the
         Securities Act. The options contain the appropriate restrictive legend
         restricting their transferability absent registration or applicable
         exemption. The employee received information concerning our company and
         had the opportunity to ask questions about the viability of our
         company.

(9)      On January 17, 2002, we issued options to purchase 2,000,000 shares of
         our common stock at an exercise price of $0.15 per share. The market
         price at the date of the grant was $0.12 per share. These options were
         issued pursuant to an employment agreement. The options vest
         periodically over the term of the agreement. The options issued to the
         employee were exempt from registration under Section 4(2) of the
         Securities Act. The options contain the appropriate restrictive legend
                                       37

         restricting their transferability absent registration or applicable
         exemption. The employee received information concerning our company and
         had the opportunity to ask questions about the viability of our
         company.

(10)     During year ended December 31, 2002, we issued stock options to
         purchase 200,000 shares of common stock to an additional employee of
         our Company. These options have an exercise price of $0.77 per share.
         The options vest periodically over the term of the agreement. The
         options issued to the employee were exempt from registration under
         Section 4(2) of the Securities Act. The options contain the appropriate
         restrictive legend restricting their transferability absent
         registration or applicable exemption. The employee received information
         concerning our company and had the opportunity to ask questions about
         the viability of our company.

(11)     During January of 2003 we issued options to purchase 10,000 shares of
         our common stock exercisable at $1.00 per share to an employee pursuant
         to a two-year employment agreement with our company. The options vest
         periodically over the term of the agreement, of which options to
         purchase 5,000 shares vested during year ended December 31, 2003. The
         options issued to the employee were exempt from registration under
         Section 4(2) of the Securities Act. The options contain the appropriate
         restrictive legend restricting their transferability absent
         registration or applicable exemption. The employee received information
         concerning our company and had the opportunity to ask questions about
         the viability of our company.

(12)     During the 2004 fiscal year, we issued options to purchase an aggregate
         of 1,394,666 shares of our common stock to our chief executive officer,
         an employee and a consultant in consideration for such individuals
         converting accrued salaries and consulting fees in the aggregate amount
         of $370,000 to equity in our Company. Options to purchase 697,333
         shares of our common stock are exercisable at $0.60 and options to
         purchase 697,333 shares of our common stock are exercisable at $1.00.
         The options are exercisable for a period of five years commencing
         January 15, 2004. Options to purchase 220,000 shares of our common
         stock were issued to Alberto DiBella. Options to purchase 1,066,666
         shares of our common stock were issued to John A. DiBella. Options to
         purchase 108,000 shares of our common stock were issued to John Combs.
         The issuance of the options to our employees was exempt from
         registration under Section 4(2) of the Securities Act. The employees
         had access to information concerning our Company and had the
         opportunity to ask questions concerning the viability of our Company.
         The options issued to our employees contain legends restricting their
         transferability absent registration or applicable exemption.

(13)     On February 18, 2004, we issued options to purchase an aggregate of
         30,000 shares of our common stock exercisable at $0.71 per share to
         three individuals as consideration for joining our advisory committee.
         The options are exercisable until February 18, 2006. The options were
         issued pursuant to the exemption from registration under Section 4(2)
         of the Securities Act. The advisors received information concerning our
         Company and had the opportunity to ask questions concerning the
         viability of our Company. The options contain legends restricting their
         transferability absent registration or applicable exemption.

(14)     Dispostive control held by Joan Rich Baer, 199 Concord Dr., Madison CT
         06443.
(15)     Dispostive control held by Richard Goodwyn, 8 North Rahallion Dr.,
         Rumson, NJ 07760.
                                       38

(16)     Dispostive control held by Robert Levy, 100 West Liberty St., Reno,
         NV 85901.
(17)     Dispostive control held by Robert Levy, 100 West Liberty St., Reno,
         NV 85901.
(18)     Dispostive control held by Richard Keyes, 1024 Glorietta, Coronado,
         CA 92118.
(19)     Dispostive control held by Bryce Carter, Suite 5050 Commerce Court
         West 199 Bay Street, Toronto, ON 5ML-1E2.
(20)     Dispostive control held by James Edgar McDonald, 6044 East Briarwood
         Dr., Centennial, CO 80112.
(21)     Dispostive control held by Virginia Stevens McDonald, 6044 East
         Briarwood Dr., Centennial, CO 80112.
(22)     Dispostive control held by Barbara J. Drew, 302 Carl Lane, Capitola,
         CA 95010.

                              PLAN OF DISTRIBUTION

         The shares of common stock owned, or which may be acquired, by the
selling shareholders may be offered and sold by means of this prospectus from
time to time as market conditions permit in the over-the-counter market, or
otherwise, at prices and terms then prevailing or at prices related to the
then-current market price, or in negotiated transactions. These shares may be
sold by one or more of the following methods, without limitation:

         o     a block trade in which a broker or dealer so engaged will attempt
               to sell the shares as agent but may position and resell a portion
               of the block as principal to facilitate the transaction;

         o     purchases by a broker or dealer as principal and resale by such
               broker or dealer for its account pursuant to this prospectus;

         o     ordinary brokerage transactions and transactions in which the
               broker solicits purchasers; and

         o     face-to-face transactions between sellers and purchasers without
               a broker/dealer.

         In effecting sales, brokers or dealers engaged by the selling
shareholders may arrange for other brokers or dealers to participate. Such
brokers or dealers may receive commissions or discounts from selling
shareholders in amounts to be negotiated.

         The selling shareholders and any broker/dealers who act in connection
with the sale of the shares hereunder may be deemed to be "underwriters" within
the meaning of section 2(11) of the Securities Acts of 1933, and any commissions
received by them and profit on any resale of the shares as principal might be
deemed to be underwriting discounts and commissions under the Securities Act. We
have agreed to indemnify the selling shareholders, and any securities
broker/dealers who may be deemed to be underwriters against certain liabilities,
including liabilities under the Securities Act as underwriters or otherwise.

         We have advised the selling shareholders that they and any securities
broker/dealers or others who may be deemed to be statutory underwriters will be
subject to the prospectus delivery requirements under the Securities Act. We
have also advised each selling shareholder that in the event of a "distribution"
of the shares owned by the selling shareholder, such selling shareholder, any
"affiliated purchasers", and any broker/dealer or other person who participates
in such distribution, may be subject to Rule 102 under the Securities Exchange
Act of 1934 until their participation in that distribution is completed. Rule
102 makes it unlawful for any person who is participating in a distribution to
bid for or purchase stock of the same class as is the subject of the
                                       39

distribution. A "distribution" is defined in Rule 102 as an offering of
securities "that is distinguished from ordinary trading transactions by the
magnitude of the offering and the presence of special selling efforts and
selling methods". We have also advised the selling shareholders that Rule 101
under the 1934 Act prohibits any "stabilizing bid" or "stabilizing purchase" for
the purpose of pegging, fixing or stabilizing the price of the common stock in
connection with this offering.

         We do not intend to distribute or deliver the prospectus by means other
than by hand or mail.

         During such time as the selling shareholders may be engaged in a
distribution of the securities covered by this prospectus, the selling
shareholders are required to comply with Regulation M promulgated under the
Exchange Act. With certain exceptions, Regulation M precludes the selling
shareholders, any affiliated purchasers, and any broker-dealer or other person
who participates in such distribution from bidding for or purchasing, or
attempting to induce any person to bid for or purchase any security which is the
subject to the distribution until the entire distribution is complete.
Regulation M also restricts bids or purchases made in order to stabilize the
price of a security in connection with the distribution of that security. All of
the foregoing may affect the marketability of our common stock.

                         SHARES ELIGIBLE FOR FUTURE SALE

         As of the date of this prospectus, we have 21,992,235 shares of common
stock issued and outstanding. This does not include shares that may be issued
upon exercise of options or warrants.

         We cannot predict the effect, if any, that market sales of common stock
or the availability of these shares for sale will have on the market price of
our shares from time to time. Nevertheless, the possibility that substantial
amounts of common stock may be sold in the public market could negatively damage
and affect market prices for our common stock and could damage our ability to
raise capital through the sale of our equity securities.

                                  LEGAL MATTERS

         The validity of the securities offered by this prospectus will be
passed upon for us by Arnstein & Lehr LLP, 200 East Las Olas Boulevard, Suite
1700, Fort Lauderdale, Florida 33301.

                                     EXPERTS

         Our consolidated financial statements as of December 31, 2006 are
included herein in reliance on the reports Jewett, Schwartz, Wolfe & Associates
& Co., LLP independent accountants, given on the authority of that firm as
experts in accounting and auditing.

                             ADDITIONAL INFORMATION

         We have filed with the SEC the registration statement on Form SB-2
under the Securities Act for the common stock offered by this prospectus. This
prospectus, which is a part of the registration statement, does not contain all
of the information in the registration statement and the exhibits filed with it,
portions of which have been omitted as permitted by SEC rules and regulations.
For further information concerning us and the securities offered by this

                                       40

prospectus, we refer to the registration statement and to the exhibits filed
with it. Statements contained in this prospectus as to the content of any
contract or other document referred to are not necessarily complete. In each
instance, we refer you to the copy of the contracts and/or other documents filed
as exhibits to the registration statement, and these statements are qualified in
their entirety by reference to the contract or document.

         The registration statement, including all exhibits, may be inspected
without charge at the SEC's Public Reference Room at 450 Fifth Street, N.W.
Washington, D.C. 20549, and at the SEC's regional offices located at the
Woolworth Building, 233 Broadway, New York, New York 10279 and Citicorp Center,
500 West Madison Street, Suite 1400, Chicago, Illinois 60661. Copies of these
materials may also be obtained from the SEC's Public Reference at 450 Fifth
Street, N.W., Room 1024, Washington D.C. 20549, upon the payment of prescribed
fees. You may obtain information on the operation of the Public Reference Room
by calling the SEC at 1-800-SEC-0330.

         The registration statement, including all exhibits and schedules and
amendments, has been filed with the SEC through the Electronic Data Gathering,
Analysis and Retrieval system, and are publicly available through the SEC's Web
site located at http://www.sec.gov.





































                                       41




                        ENVIRO VORAXIAL TECHNOLOGY, INC.
                                 AND SUBSIDIARY


                       CONSOLIDATED FINANCIAL INFORMATION
                               September 30, 2007



                                     Table of Contents
                                                                                                          Page
                                                                                                          ----
                                                                                                          
             Consolidated Balance Sheet...............................................................     F-2

             Consolidated Statements of Operations....................................................     F-3

             Consolidated Statement of Changes in Shareholders' Equity................................     F-4

             Consolidated Statements of Cash Flows ...................................................     F-5

             Notes to Consolidated Financial Statements...............................................     F-6






























                                      F-1



                 ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY
                           CONSOLIDATED BALANCE SHEET

                                                                                                  September 30,
                                                                                                      2007
                                                                                                   (Unaudited)
                                                                                            --------------------------
                                                                                         
                       ASSETS

CURRENT ASSETS:
      Cash and cash equivalents                                                             $                 250,140
      Accounts receivable, net                                                                                 59,862
      Inventory                                                                                               417,041
                                                                                            --------------------------

        Total current assets                                                                                  727,043

 FIXED ASSETS, NET                                                                                            219,192

 OTHER ASSETS                                                                                                  13,695
                                                                                            --------------------------

    Total assets                                                                            $                 959,930
                                                                                            ==========================

                              LIABILITIES AND SHAREHOLDERS' EQUITY

 CURRENT LIABILITIES:
       Accounts payable and accrued expenses                                                $                 618,017
                                                                                            --------------------------

        Total current liabilities                                                                             618,017
                                                                                            --------------------------
 LONG TERM LIABILITIES
          Note Payable - Equipment                                                                            180,098
                                                                                            --------------------------

 TOTAL LIABILITIES                                                                                            798,115
                                                                                            --------------------------
 COMMITMENTS AND CONTINGENCIES

 SHAREHOLDERS' EQUITY:
 Common stock, $.001 par value, 42,750,000 shares authorized;
 22,872,235 shares issued and outstanding                                                                      22,871
 Additional paid-in capital                                                                                 8,371,107
 Accumulated deficit                                                                                       (8,232,163)
                                                                                            --------------------------

        Total shareholders' equity                                                                            161,815
                                                                                            --------------------------

 Total liabilities and shareholders' equity                                                 $                 959,930
                                                                                            ==========================


The accompanying notes are an integral part of the consolidated financial
statements.
                                       F-2



                 ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY
                     CONSOLIDATED STATEMENTS OF OPERATIONS

                                                      Three Months Ended September 30,       Nine Months Ended September 30,
                                                    ------------------------------------  ------------------------------------
                                                          2007                2006             2007                2006
                                                    ----------------    ----------------  --------------    ------------------
                                                                                                 
Revenues, net                                          $     22,518      $       46,261    $     286,676     $       208,425

Cost of goods sold                                           40,669               6,423           77,246              71,410
                                                    ----------------   ----------------- ----------------  ------------------

Gross profit (loss)                                         (18,151)             39,838          209,430             137,015

Costs and operating expenses:
      Research and development                              135,479             102,408          305,327             281,124
      General and administrative                            192,433             135,748        1,420,730             441,257
                                                    ----------------   ----------------- ----------------  ------------------


         Total costs and operating expenses                 327,912             238,156        1,726,057             722,381
                                                    ----------------   ----------------- ----------------  ------------------

Loss from operations                                       (346,063)           (198,318)      (1,516,627)           (585,366)

Provision for income taxes                                        -                   -                -                   -
                                                    ----------------   ----------------- ----------------  ------------------

NET LOSS                                               $   (346,063)     $     (198,318)   $  (1,516,627)    $      (585,366)
                                                    ================   ================= ================  ==================

Weighted average number of common shares
   outstanding-basic & diluted                           22,872,235          20,751,262       22,008,254          20,067,888
                                                    ================   ================= ================  ==================

Basic and diluted loss per common share                $      (0.02)     $        (0.01)   $       (0.07)    $         (0.03)
                                                    ================   ================= ================  ==================





















The accompanying notes are an integral part of the consolidated financial
statements.
                                       F-3



                 ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY
           CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY


                                                 Common Stock           Additional
                                           -------------------------      Paid-in       Deferred     Accumulated
                                              Shares        Amount       Capital      Compensation      Deficit        Total
                                              ------        ------       -------      ------------      -------        -----
                                                                                                   
Balance at December 31, 2004                17,676,402    $   18,000   $ 4,953,000   $   (11,000)    $ (4,791,000)   $  169,000

Issuance of common stock for
  consulting services                          300,000           300       141,519       (56,875)               -        84,944
Issuance of options for services                     -             -        21,000             -                -        21,000
Issuance of restricted common
  stock at $.40 per share                    1,468,333         1,144       586,189             -                -       587,333
Issuance of common stock for
  consulting services                           15,000            15         7,635             -                -         7,650
Amortization of deferred compensation                -             -             -        14,438                -        14,438
Net loss                                             -             -             -             -       (1,091,005)   (1,091,005)
                                           ------------   ----------- -------------  ------------  ---------------  ------------

Balance - December 31, 2005                 19,459,735    $   19,459   $ 5,709,343   $   (53,437)    $ (5,882,005)   $ (206,640)

Issuance of common stock for investments     2,232,500         2,232       890,768             -                -       893,000
Issuance of restricted common stock at
  $.40 per share                               300,000           300       119,700       (13,333)               -       106,667
Amortization of deferred compensation                -             -             -        53,437                -        53,437
Net loss                                             -             -             -             -         (833,531)     (833,531)
                                           ------------   ----------- -------------  ------------  ---------------  ------------

Balance - December 31, 2006                 21,992,235    $   21,991   $ 6,719,811   $   (13,333)    $ (6,715,536)   $   12,933

Issuance of options for accrued salary               -             -       360,000             -                -       360,000
Issunace of options for services                     -             -        86,676             -                -        86,676
Issuance of common stock for
  consulting services                          100,000           100        39,900       (13,333)               -        26,667
Extension of options issued                          -             -       697,500             -                -       697,500
Amortization of deferred compensation                -             -             -        13,333                -        13,333
Net loss                                             -             -             -             -       (1,127,144)   (1,127,144)
                                           ------------   ----------- -------------  ------------  ---------------  ------------

Balance - March 31, 2007                    22,092,235    $   22,091   $ 7,903,887   $   (13,333)    $ (7,842,680)   $   69,965

Issuance of common stock                       780,000           780       467,220             -                -       468,000
Amortization of deferred compensation                -             -             -        13,333                -        13,333
Net loss                                             -             -             -             -          (43,420)      (43,420)
                                           ------------   ----------- -------------  ------------  ---------------  ------------

Balance - June 30, 2007                     22,872,235    $   22,871   $ 8,371,107   $        (0)    $ (7,886,100)   $  507,878

Net loss                                             -             -             -             -         (346,063)     (346,063)
                                           ------------   ----------- -------------  ------------  ---------------  ------------

Balance - September 30, 2007                22,872,235    $   22,871   $ 8,371,107   $         -     $ (8,232,163)   $  161,815
                                           ============   =========== =============  ============  ===============  ============







The accompanying notes are an integral part of the consolidated financial
statements.
                                       F-4



                 ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY
                CONSOLIDATED STATEMENTS OF CHANGES IN CASH FLOWS

                                                                           For Nine Months Ended September 30,
                                                                    --------------------------------------------------
                                                                             2007                       2006
                                                                    -----------------------    -----------------------
                                                                                         
Cash Flows From Operating Activities:
Net loss                                                            $           (1,516,627)    $             (585,366)
Adjustments to reconcile net loss to net
cash used by operating activities:
      Depreciation                                                                   6,218                        513
Common stock issued for services                                                    40,000                     60,000
Amortization of deferred compensation                                               13,333                     33,367
Deferred compensation                                                                    -                     20,000
Issuance of common stock for consulting services                                   446,676
Extension of stock options issued                                                  697,500
Changes in operating assets and liabilities:
Accounts receivable                                                                  1,479                    (41,430)
Inventory                                                                         (218,895)                   (71,098)
Prepaid insurance                                                                        -                     (8,997)
Accounts payable and accrued expenses                                              (33,685)                   164,812
Deposits                                                                            (3,695)                         -
                                                                    -----------------------    -----------------------

Net cash used in operating activities                                             (567,696)                  (428,199)
                                                                    -----------------------    -----------------------

Cash Flows From Investing Activities:
   Purchase of equipment                                                          (220,655)                         -
                                                                    -----------------------    -----------------------

Net cash used in investing activities                                             (220,655)                         -
                                                                    -----------------------    -----------------------

Cash Flows From Financing Activities:
      Equipment financing                                                          180,098
   Proceeds from sales of common stock                                             468,000                    733,000
                                                                    -----------------------    -----------------------

Net cash provided by financing activities                                          648,098                    733,000
                                                                    -----------------------    -----------------------

Net increase in cash and cash equivalents                                         (140,253)                   304,801

Cash and cash equivalents, beginning of period                                     390,393                     76,691
                                                                    -----------------------    -----------------------

Cash and cash equivalents, end of period                            $              250,140     $              381,492
                                                                    =======================    =======================

Supplemental Disclosures

Cash paid during the year for interest                              $                    -     $                    -
                                                                    =======================    =======================
Cash paid during the year for taxes                                 $                    -     $                    -
                                                                    =======================    =======================
Common stock issued for deferred consulting                         $                    -     $               20,000
                                                                    =======================    =======================
Common stock issued for consulting services                         $               40,000     $               60,000
                                                                    =======================    =======================

The accompanying notes are an integral part of the consolidated financial
statements.
                                       F-5

                        ENVIRO VORAXIAL TECHNOLOGY, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007


NOTE A - ORGANIZATION AND OPERATIONS

Organization
------------

Enviro Voraxial Technology, Inc. (the "Company") is a provider of environmental
and industrial separation technology. The Company has developed and patented the
Voraxial(R) Separator, which is a technology that efficiently separates solids
and liquids with distinct specific gravities. Potential commercial applications
and markets include oil exploration and production, oil and water separation,
environmental cleanup and pre-treatment of wastewater at municipal wastewater
(headworks) facilities.

Florida Precision Aerospace, Inc. (FPA) is the wholly owned subsidiary of the
Company and is used to do contract work with the aerospace, automotive and
defense contracting activity.

NOTE B - GOING CONCERN

The Company has experienced net losses and negative cash flows from operating
activities. They will need to raise capital to sustain operations. There is no
assurance that the Company will ever have commercially accepted products, that
their developmental and marketing efforts will be successful or that they will
achieve a level of revenue sufficient to provide cash inflows to sustain
operations. The Company will continue to require the infusion of capital until
operations become profitable. During 2007, the Company anticipates seeking
additional capital, increasing sales of the Voraxial(R) Separator and continuing
to restrict expenditures. As a result of the above, the accompanying
consolidated financial statements have been prepared assuming that the Company
will continue as a going concern. The consolidated financial statements do not
include any adjustments that might result from the outcome of this uncertainty.

NOTE C - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Interim Financial Statements
----------------------------

The interim financial statements presented herein have been prepared pursuant to
the rules and regulations of the Securities and Exchange Commission ("SEC").
Certain information and footnote disclosures normally included in financial
statements prepared in accordance with accounting principles generally accepted
in the United States of America have been condensed or omitted pursuant to such
rules and regulations. The interim financial statements should be read in
conjunction with the Company's annual financial statements, notes and accounting
policies included in the Company's annual report on Form 10-KSB for the year
ended December 31, 2006 as filed with the SEC. In the opinion of management, all
adjustments (consisting only of normal recurring adjustments) which are
necessary to provide a fair presentation of financial position as of September
30, 2007 and the related operating results and cash flows for the interim period
presented have been made. The results of operations, for the period presented
are not necessarily indicative of the results to be expected for the year.
                                       F-6

                        ENVIRO VORAXIAL TECHNOLOGY, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007

Recent Accounting Pronouncements
--------------------------------

In February 2007, the Financial Accounting Standards Board (FASB) issued
Statement of Financial Accounting Standards (SFAS) No. 159, "The Fair Value
Option for Financial Assets and Financial Liabilities - Including an amendment
of FASB Statement No. 115" ("SFAS No. 159"). SFAS No. 159 allows companies to
choose to measure many financial instruments and certain other items at fair
value. SFAS No. 159 will become effective for the Company beginning in fiscal
2009. The Company is currently evaluating what effects the adoption of SFAS No.
159 will have on the Company's future results of operations and financial
condition

NOTE D - CAPITAL TRANSACTIONS

Common stock
------------

In February 2007, the company entered into a three month consulting agreement
and agreed to issue 100,000 shares of common stock for services preformed by a
consultant which were valued at $40,000.

During the nine months ended September 30, 2007 the Company sold 780,000 shares
of common stock for $.60 per share in a private placement offering. Total
proceeds from the sale were $468,000.

Warrants
--------

In January 2007, the Company extended the exercisable life of certain warrants
issued to investors to purchase an aggregate of 243,200 shares of common stock
issued in 2000 for a period of one year. The warrants now expire in February
2008. The purchase price of these warrants ranges from $6.00 - $9.00 per share.
The Company calculated the fair value of the extended warrants by using the
Black-Scholes option-pricing model with the following weighted average
assumptions: no dividend yield for all the years; expected volatility of 25%;
risk-free interest rate of 5% and an expected life of five years. No increase in
fair value was noted and, therefore, no adjustment has been made to the
financial statements as of September 30, 2007.

In January 2007, the Company extended the exercisable life of certain warrants
issued to investors to purchase an aggregate of 200,000 shares of common stock
issued in 2001 for a period of one year. The warrants now expire in April 2008.
The purchase price of the stock under these warrants ranges from $3.00-$4.00 per
share. The Company calculated the fair value of the extended warrants by using
the Black-Scholes option-pricing model with the following weighted average
assumptions: no dividend yield for all the years; expected volatility of 25%;
risk-free interest rate of 5% and an expected life of five years. No increase in
fair value was noted and, therefore, no adjustment has been made to the
financial statements as of September 30, 2007.




                                       F-7

                        ENVIRO VORAXIAL TECHNOLOGY, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007


NOTE D - CAPITAL TRANSACTIONS (CONTINUED)

Options extended
----------------

In January 2007, the Company extended the exercisable life of certain options
issued to an employee and consultant to purchase an aggregate of 2,000,000
shares of common stock issued in 2002 for a period of five years. The options
continue to be exercisable at $0.15 per share, fully vested and now expire on
January 31, 2012. The Company calculated the fair value of the options at the
extended grant date by using the Black-Scholes option-pricing model with the
following weighted average assumptions: no dividend yield for all the years;
expected volatility of 25%; risk-free interest rate of 5% and an expected life
of five years. This results in fair value of approximately $687,000, which has
been recorded as compensation expense for the nine months ended September 30,
2007.

In January 2007, the Company extended the exercisable life of certain options
issued to an employee and consultant to purchase an aggregate of 200,000 shares
of common stock issued in 2002 for a period of five years. The options continue
to be exercisable at $0.77 per share, fully vested and now expire on January 31,
2012. The Company calculated the fair value of the options at the extended grant
date by using the Black-Scholes option-pricing model with the following weighted
average assumptions: no dividend yield for all the years; expected volatility of
25%; risk-free interest rate of 5% and an expected life of five years. No fair
value was associated with these options as a result and not adjustment has been
made to the financial statements as of September 30, 2007.

In January 2007, the Company extended the exercisable life of certain options
issued an employee to purchase an aggregate of 45,000 shares of common stock
issued in 2001 for a period of five years. The options now expire in February
2011. These options are fully vested and continue to be exercisable at $0.30 per
share. The Company calculated the fair value of the options at the extended
grant date by using the Black-Scholes option-pricing model with the following
weighted average assumptions: no dividend yield for all the years; expected
volatility of 25%; risk-free interest rate of 5% and an expected life of five
years. This results in a fair value of approximately $10,500, which has been
recorded as compensation expense for the nine months ended September 30, 2007.

Options granted
---------------

In January 2007, the Company granted 2,000,000 stock options to officers to
reduce the amount of accrued salaries and consulting fees due to them by
$300,000. The options are exercisable at $0.40 per share. These options are
fully vested and expire on January 31, 2012. The Company calculated the fair
value of the options at the grant date by using the Black-Scholes option-pricing
model with the following weighted average assumptions: no dividend yield for all
the years; expected volatility of 25%; risk-free interest rate of 5% and an
expected life of five years. This results in a fair value of approximately
$360,000, of which $300,000 was previously recorded as compensation expense. The
                                       F-8

                        ENVIRO VORAXIAL TECHNOLOGY, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007

NOTE D - CAPITAL TRANSACTIONS (CONTINUED)

remaining $60,000 has been recorded as compensation expense for the nine months
ended September 30, 2007.

In January 2007, the Company granted 606,000 stock options to employees or
outside consultants, exercisable at $0.40 per share. These options vest equally
over the life of the options, which range from 1 to 5 years. The Company
calculated the fair value of the options at the grant date by using the
Black-Scholes option-pricing model with the following weighted average
assumptions: no dividend yield for all the years; expected volatility of 25%;
risk-free interest rate of 5% and an expected life of 1 to 5 years, resulting in
a fair value of approximately $86,000.

In January 2007, the Company issued 375,000 stock options to a consultant,
exercisable at $0.80 -$1.00 per share. These options are fully vested and expire
on October 31, 2007. The Company calculated the fair value of the options at the
grant date by using the Black-Scholes option-pricing model with the following
weighted average assumptions: no dividend yield for all the years; expected
volatility of 25%; risk-free interest rate of 5% and an expected life of 10
months. Based on the above, the options were not considered to have a fair value
associated with them.

Options-additional information
------------------------------

Information with respect to employee stock options outstanding and employee
stock options exercisable at September 30, 2007 is as follows:


----------------------------------------------------------------------------------------------------------------------------
                                                                                                           Weighted Average
                                                          Options        Vested       Exercise Price Per  Exercise Price Per
                                                        Outstanding      Shares          Common Share     Option Outstanding
----------------------------------------------------------------------------------------------------------------------------
                                                                                                   
Balance, December 31, 2006                               3,729,666       3,709,666         $0.15-$1.00            $0.52
----------------------------------------------------------------------------------------------------------------------------
Granted/vested during the period ended September 30,     2,981,000       2,981,000               $0.40            $0.40
2007
----------------------------------------------------------------------------------------------------------------------------
Balance, September 30, 2007                              6,710,666       3,709,666         $0.15-$1.00            $0.46
----------------------------------------------------------------------------------------------------------------------------












                                       F-9

                        ENVIRO VORAXIAL TECHNOLOGY, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007

NOTE D - CAPITAL TRANSACTIONS (CONTINUED)

The following table summarizes information about the stock options outstanding
at September 30, 2007:


------------------------------------------------------------------------------------------------------------------------------
                                                 Weighted Average
        Exercise         Number Outstanding         Remaining      Weighted Average    Number Exercisable at  Weighted Average
          Price         at September 30, 2007    Contractual Life    Exercise Price      September 30, 2007     Exercise Price
------------------------------------------------------------------------------------------------------------------------------
                                                                                                   
            0.30                 45,000               3.25               0.30                   45,000               0.30
------------------------------------------------------------------------------------------------------------------------------
            0.77                200,000               4.25               0.77                  200,000               0.77
------------------------------------------------------------------------------------------------------------------------------
            0.15              2,000,000               4.25               0.15                2,000,000               0.15
------------------------------------------------------------------------------------------------------------------------------
            1.00                 10,000                .08               1.00                   10,000               1.00
------------------------------------------------------------------------------------------------------------------------------
            0.60                697,333               1.25               0.60                  697,333               0.60
------------------------------------------------------------------------------------------------------------------------------
            1.00                697,333               1.25               1.00                  697,333               1.00
------------------------------------------------------------------------------------------------------------------------------
            1.00                 50,000               3.00               1.00                   50,000               1.00
------------------------------------------------------------------------------------------------------------------------------
            0.71                 30,000                .25               0.71                   30,000               0.71
            0.40              2,981,000               4.25               0.40                2,981,000               0.40
                              ---------                                                      ---------
                              6,710,666                                                      6,710,666
                              =========                                                      =========
------------------------------------------------------------------------------------------------------------------------------























                                       F-10

                        ENVIRO VORAXIAL TECHNOLOGY, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007


NOTE D - CAPITAL TRANSACTIONS (CONTINUED)

Warrants
--------

Information with respect to warrants outstanding and exercisable at September
30, 2007 is as follows:


---------------------------------------------------------------------------------------------------------------
                                                   Number                  Range of                Number
                                                Outstanding             Exercise Price           Exercisable
---------------------------------------------------------------------------------------------------------------
                                                                                      
Balance, December 31, 2006                        5,589,367             $0.75 - $9.00             5,389,367
---------------------------------------------------------------------------------------------------------------
Issued                                                    -                                               -
---------------------------------------------------------------------------------------------------------------
Balance, September 30, 2007                       5,589,367               $0.75-$9.00             5,389,367
---------------------------------------------------------------------------------------------------------------


NOTE E - RELATED PARTY TRANSACTIONS

For the nine months ended September 30, 2007, the Company incurred consulting
expenses from the chief executive officer and majority stockholder of the
Company of $173,750. Of these amounts, $43,000 has been paid out for the nine
months ended September 30, 2007. The accumulated unpaid balance has been
included in accrued expenses.

NOTE F - CONCENTRATION

Revenues
--------

For the nine months ended September 30, 2007, the Company generated over 80% of
its revenues from one customer.

















                                       F-11





                                     ENVIRO VORAXIAL TECHNOLOGY, INC.
                                              AND SUBSIDIARY


                                           FINANCIAL STATEMENTS

                                            DECEMBER 31, 2006




                                            Table of Contents
                                                                                              Page
                                                                                              ----

                                                                                           
Report of Independent Registered Public Accounting Firm................................       F - 2

Balance Sheet  ........................................................................       F - 3

Statements of Operations ..............................................................       F - 4

Statements of Changes in Shareholders' Deficiency......................................       F - 5

Statements of Cash Flows ..............................................................       F - 6

Notes to Financial Statements..........................................................       F -7 -18

































                                      F-1

             Report of Independent Registered Public Accounting Firm



To The Shareholders and Board of Directors of
         Enviro Voraxial Technology, Inc.

We have audited the accompanying consolidated balance sheet of Enviro Voraxial
Technology, Inc and Subsidiary as of December 31, 2006 and the related
consolidated statements of operations, changes in shareholders' deficiency and
cash flows for years end December 31, 2006 and 2005. These financial statements
are the responsibility of the Company's management. Our responsibility is to
express an opinion on these financial statements based on our audits.

We conducted our audit in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provided a
reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of Enviro Voraxial Technology, Inc
and Subsidiary as of December 31, 2006 and 2005, and the results of its
operations and its cash flows for the years then ended in conformity with
accounting principles generally accepted in the United States.

The accompanying consolidated financial statements have been prepared assuming
that Enviro Voraxial Technology, Inc and Subsidiary will continue as a going
concern. As discussed in Note B to the financial statements, Enviro Voraxial
Technology, Inc and Subsidiary has suffered recurring losses from operations,
which raises substantial doubt about its ability to continue as a going concern.
Management's plans regarding those matters also are described in Note B. The
financial statements do not include any adjustments that might result from the
outcome of this uncertainty.




Jewett, Schwartz, Wolfe & Associates

Hollywood, Florida
April 16, 2007









                                       F-2




                 ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY
                            CONSOLIDATED BALANCE SHEET

                                                                                              December 31,
                                                                                                 2006
                                                                                           -----------------
                                                                                        
                                      ASSETS

CURRENT ASSETS:
      Cash and cash equivalents                                                            $         390,393
      Accounts receivable, net                                                                        61,341
      Inventory                                                                                      198,146
                                                                                           -----------------

        Total current assets                                                                         649,880

 FIXED ASSETS, NET                                                                                     4,755

 OTHER ASSETS                                                                                         10,000
                                                                                           -----------------

    Total assets                                                                           $         664,635
                                                                                           =================


                     LIABILITIES AND SHAREHOLDERS' DEFICIENCY

 CURRENT LIABILITIES:
       Accounts payable and accrued expenses                                               $         651,702
                                                                                           -----------------

        Total current liabilities                                                                    651,702
                                                                                           -----------------


        Total liabilities                                                                            651,702
                                                                                           -----------------

 COMMITMENTS AND CONTINGENCIES

 SHAREHOLDERS' DEFICIENCY:
 Common stock, $.001 par value, 42,750,000 shares authorized
      21,992,235 shares issued and oustanding                                                         21,991
 Additional paid-in capital                                                                        6,719,811
 Deferred compensation                                                                               (13,333)
 Accumulated deficit                                                                              (6,715,536)
                                                                                           -----------------

        Total shareholders' equity                                                                    12,933
                                                                                           -----------------

 Total liabilities and shareholders' deficiency                                            $         664,635
                                                                                           =================











        The accompanying notes are an integral part of the consolidated
                             financial statements.

                                      F-3



                 ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY
                      CONSOLIDATED STATEMENTS OF OPERATIONS



                                                                              Years Ended December 31,
                                                                            ------------    ------------
                                                                                2006            2005
                                                                            ------------    ------------
                                                                                      
Revenues, net                                                               $    310,376    $    128,070

Cost of goods sold                                                               134,499          34,444
                                                                            ------------    ------------

Gross profit                                                                     175,877          93,626

Costs and operating expenses:
      Research and development                                                   592,181         730,774
      General and administrative                                                 421,975         455,999
                                                                            ------------    ------------


                Total costs and operating expenses                             1,014,156       1,186,773
                                                                            ------------    ------------

Loss from operations                                                            (838,279)     (1,093,147)
                                                                            ------------    ------------

Other income:
      Interest income                                                              4,748              --
      Gain on sale of asset                                                           --           2,142
                                                                            ------------    ------------

              Total other income                                                   4,748           2,142
                                                                            ------------    ------------

Provision for income taxes                                                            --              --

NET LOSS                                                                    $   (833,531)   $ (1,091,005)
                                                                            ============    ============

Weighted average number of common shares
   outstanding-basic & diluted                                                18,257,808      18,257,808
                                                                            ============    ============

Basic and diluted loss per common share                                     $      (0.05)   $      (0.06)
                                                                            ============    ============











        The accompanying notes are an integral part of the consolidated
                             financial statements.

                                      F-4



                 ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY
         CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIENCY



                                            Common Stock          Additional
                                      -------------------------    Paid-in       Deferred    Accumulated
                                        Shares         Amount      Capital     Compensation    Deficit        Total
                                      ------------   ----------  ------------ -------------  ------------  ------------
                                                                                         
Balance at December 31, 2004           17,676,402    $   18,000  $ 4,953,000  $    (11,000) $ (4,791,000)  $    169,000

Issuance of common stock for
   consulting services                    300,000           300      141,519       (56,875)           --         84,944
Issuance of options for services               --            --       21,000            --            --         21,000
Issuance of restricted common
  stock at $.40 per share               1,468,333         1,144      586,189            --            --        587,333
Issuance of common stock for
  consulting services                      15,000            15        7,635            --            --          7,650
Amortization of deferred
  compensation                                 --            --           --        14,438            --         14,438
Net loss                                       --            --           --            --    (1,091,005)    (1,091,005)
                                      -----------    ----------  -----------  ------------  ------------   ------------

Balance - December 31, 2005            19,459,735    $   19,459  $ 5,709,343  $    (53,437) $ (5,882,005)  $   (206,640)

Issuance of common stock
  for investments                       2,232,500         2,232      890,768            --            --        893,000
Issuance of restricted common
   stock at $.40 per share                300,000           300      119,700       (13,333)           --        106,667
Amortization of deferred compensation          --            --           --        53,437            --         53,437
Net loss                                       --            --           --            --      (833,531)      (833,531)
                                      -----------    ----------  -----------  ------------  ------------   ------------

Balance - December 31, 2006            21,992,235    $   21,991  $ 6,719,811  $    (13,333) $ (6,715,536)  $     12,933
                                      ===========    ==========  ===========  ============  ============   ============






















        The accompanying notes are an integral part of the consolidated
                             financial statements.

                                      F-5



                 ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY
                CONSOLIDATED STATEMENTS OF CHANGES IN CASH FLOWS

                                                                                     For the Years Ended December 31,
                                                                                     --------------------------------
                                                                                           2006             2005
                                                                                     --------------    --------------
                                                                                                 
Cash Flows From Operating Activities:
Net loss                                                                                $  (833,531)   $(1,091,005)
Adjustments to reconcile net loss to net
  cash used by operating activities:
      Depreciation                                                                              583          2,720
      Common stock issued for services                                                           --        149,469
      Amortization of deferred compensation                                                  53,437             --
      Deferred compensation                                                                 (13,333)       (42,437)
      Gain on sale of equipment                                                                  --         (2,142)
      Issuance of warrants for services                                                          --         21,000
Changes in operating assets and liabilities:
      Accounts receivable                                                                   (61,341)            --
      Inventory                                                                             (72,112)       (47,034)
      Prepaid insurance                                                                          --          3,000
      Accounts payable and accrued expenses                                                 226,999        255,617
      Deposits from customers                                                                    --        (10,000)
                                                                                        -----------    -----------

Net cash used in operating activities                                                      (699,298)      (760,812)
                                                                                        -----------    -----------

Cash Flows From Investing Activities:
   Purchase of equipment                                                                         --         (5,830)
   Sale of equipment                                                                             --         35,000
                                                                                        -----------    -----------

Net cash provided by investing activities                                                        --         29,170
                                                                                        -----------    -----------

Cash Flows From Financing Activities:
   Proceeds from sales of common stock                                                    1,013,000        587,333
                                                                                        -----------    -----------

Net cash provided by financing activities                                                 1,013,000        587,333
                                                                                        -----------    -----------

Net increase (decrease) in cash and cash equivalents                                        313,702       (144,309)

Cash and cash equivalents, beginning of period                                               76,691        221,000
                                                                                        -----------    -----------

Cash and cash equivalents, end of period                                                $   390,393    $    76,691
                                                                                        ===========    ===========

Supplemental Disclosures

     Cash paid during the year for interest                                             $        --    $        --
                                                                                        ===========    ===========
     Cash paid during the year for taxes                                                $        --    $        --
                                                                                        ===========    ===========
     Common stock issued for deferred consulting                                        $    13,333    $    53,437
                                                                                        ===========    ===========
     Common stock issued for consulting services                                        $   286,667    $   146,469
                                                                                        ===========    ===========






        The accompanying notes are an integral part of the consolidated
                             financial statements.

                                      F-6


                        ENVIRO VORAXIAL TECHNOLOGY, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                DECEMBER 31, 2006


NOTE A - ORGANIZATION AND OPERATIONS

Organization
------------
Enviro Voraxial Technology, Inc. (the "Company") is a provider of environmental
and industrial separation technology. The Company has developed and patented the
Voraxial(R) Separator, which is a technology that efficiently separates solids
and liquids with distinct specific gravities. Potential commercial applications
and markets include oil exploration and production, oil refineries, mining,
manufacturing and municipal wastewater industry.

The Company currently operates within one segment,which is the manufacture and
sale of the Voraxial(R) Separator.

Florida Precision Aerospace, Inc. (FPA) is the wholly-owned subsidiary of the
Company and is used to manufacture, assemble and test the Voraxial Separator.

NOTE B - GOING CONCERN

The Company has experienced net losses, has negative cash flows from operating
activities, and has to raise capital to sustain operations. There is no
assurance that the Company's developmental and marketing efforts will be
successful, that the Company will ever have commercially accepted products, or
that the Company will achieve a level of revenue sufficient to provide cash
inflows to sustain operations. The Company will continue to require the infusion
of capital until operations become profitable. During 2007, the Company
anticipates seeking additional capital, increasing sales of the Voraxial(R)
Separator and continuing to restrict expenditures. As a result of the above, the
accompanying consolidated financial statements have been prepared assuming that
the Company will continue as a going concern. The consolidated financial
statements do not include any adjustments that might result from the outcome of
this uncertainty.

NOTE C - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation
---------------------------
The consolidated financial statements include the accounts of the parent
company, Enviro Voraxial Technology, Inc., and its wholly-owned subsidiary,
Florida Precision Aerospace, Inc. All significant intercompany accounts and
transactions have been eliminated.

Estimates
---------
The preparation of consolidated financial statements in conformity with
accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosures of contingent assets and
liabilities at the date of the financial statements and the reported amounts of
revenue and expenses during the reporting period. Actual results may differ.

                                      F-7

                        ENVIRO VORAXIAL TECHNOLOGY, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                DECEMBER 31, 2006

Revenue Recognition
-------------------
The Company presents revenue in accordance with Staff Accounting Bulletin (SAB)
No. 104 "Revenue Recognition in Financial Statements". Under SAB No.104, revenue
is realized when persuasive evidence of an arrangement exists, delivery has
occurred, the price is fixed or determinable and collectibility is reasonably
assured.

In accordance with the above, the Company recognizes revenues from contracts
upon customer acceptance of shipment.

Fair Value of Instruments
-------------------------
The carrying amounts of the Company's financial instruments, including cash and
cash equivalents, inventory, accounts payable and accrued expenses at December
31, 2006, approximate their fair value because of their relatively short-term
nature.

Cash and Cash Equivalents
-------------------------
The Company considers all highly liquid investments with a maturity of three
months or less at the date of purchase to be cash equivalents. The Company
maintains its cash balances with various financial institutions. Balances at
these institutions may at times exceed the Federal Deposit Insurance Corporate
limits.

Inventory
---------
Inventory consists of components for the Voraxial(R) Separator and is priced at
lower of first-in, first-out cost or market. Inventory includes components held
by third parties in connection with pilot programs as part of the continuing
evaluation by such third parties as to the effectiveness and usefulness of the
service to be incorporated into their respective operations.

Fixed Assets
------------
Fixed assets are stated at cost less accumulated depreciation. The cost of
maintenance and repairs is expensed to operations as incurred. Depreciation is
computed by the straight-line method over the estimated economic useful life of
the assets (5-10 years). Gains and losses recognized from the sales or disposal
of assets is the difference between the sales price and the recorded cost less
accumulated depreciation less costs of disposal.

Net Loss Per Share
------------------
Basic and diluted loss per share has been computed by dividing the net loss
available to common stockholders by the weighted average number of common shares
outstanding. The warrants and stock options have been excluded from the
calculation since they would be anti-dilutive.

                                      F-8

                        ENVIRO VORAXIAL TECHNOLOGY, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                DECEMBER 31, 2006


Such equity instruments may have a dilutive effect in the future and include the
following potential common shares:

                  Warrants                                      5,589,367
                  Stock options                                 3,729,666
                                                               ----------
                                                                9,319,033
                                                               ==========
Income Taxes
------------
Deferred income taxes are recognized for the tax consequences in future years of
differences between the tax bases of assets and liabilities and their financial
reporting amounts based on enacted tax laws and statutory tax rates applicable
to the periods in which the differences are expected to affect taxable income.
Valuation allowances are established when necessary to reduce deferred tax
assets to the amount expected to be realized.

Research and Development Expenses
---------------------------------
Research and development costs, which consist of travel expenses, consulting
fees, subcontractors and salaries are expensed as incurred.

Advertising Costs
-----------------
Advertising costs are expensed as incurred and are included in general and
administrative expenses. Amounts incurred for advertising as of December 31,
2006 and 2005 were $8,833 and $10,121 respectively.

Stock-Based Compensation
------------------------
The company adopted SFAS No. 123(R) effective January 1, 2006. This statement
requires compensation expense relating to share-based payments to be recognized
in net income using a fair-value measurement method. Under the fair value
method, the estimated fair value of awards is charged to income on a
straight-line basis over the requisite service period, which is generally the
vesting period. The company elected the modified prospective method as
prescribed in SFAS No. 123 (R) and therefore, prior periods were not restated.
Under the modified prospective method, this statement was applied to new awards
granted after the time of adoption, as well as to the unvested portion of
previously granted equity-based awards for which the requisite service has not
been rendered as of January 1, 2006.

Prior to January 1, 2006, the Company accounted for stock-based employee
compensation under Accounting Principles Board (APB) Opinion No. 25, "Accounting
for Stock Issued to Employees," and related interpretations. The Company has
adopted the disclosure-only provisions of Statement of Financial Accounting
Standards (SFAS) No. 123, "Accounting for Stock-Based Compensation," and SFAS
No. 148, "Accounting for Stock-Based Compensation - Transition and Disclosure,"
which was released in December 2002 as an amendment of SFAS No. 123. The Company
currently accounts for stock-based compensation under the fair value method
using the Black-Scholes option pricing model as indicated in Note G.

                                      F-9

                        ENVIRO VORAXIAL TECHNOLOGY, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                DECEMBER 31, 2006


Accounting for the Impairment of Long-Lived Assets
--------------------------------------------------
The long-lived assets held and used by the Company are reviewed for impairment
whenever events or changes in circumstances indicate that the carrying amount of
assets may not be recoverable. It is reasonably possible that these assets could
become impaired as a result of technology or other industry changes.
Determination of recoverability of assets to be held and used is by comparing
the carrying amount of an asset to future net undiscounted cash flows to be
generated by the assets. If such assets are considered to be impaired, the
impairment to be recognized is measured by the amount by which the carrying
amount of assets exceeds the fair value of the assets. Assets to be disposed of
are reported at the lower of the carrying amount or fair value less costs to
sell. There were no impairments of long-lived assets in 2006.

Recent Accounting Pronouncements
--------------------------------

Accounting changes and error corrections
----------------------------------------

In May 2005, the Financial Accounting Standards Board (FASB) issued SFAS No.
154, "Accounting Changes and Error Corrections" (SFAS 154), which replaces
Accounting Principles Board (APB) Opinion No. 20, "Accounting Changes," and SFAS
No. 3, "Reporting Accounting Changes in Interim Financial Statements - An
Amendment of APB Opinion No. 28." SFAS 154 provides guidance on the accounting
for and reporting of accounting changes and error corrections, and it
establishes retrospective application, or the latest practicable date, as the
required method for reporting a change in accounting principle and the reporting
of a correction of an error. SFAS 154 is effective for accounting changes and
corrections of errors made in fiscal years beginning after December 15, 2006.
The Company will adopt SFAS 154 in the first quarter of fiscal year 2007 and
does not expect it to have a material impact on its consolidated results of
operations and financial condition.

Fair value measurements
-----------------------

In September 2006, the FASB issued SFAS No. 157, "Fair Value Measurements" (SFAS
157). SFAS 157 provides guidance for using fair value to measure assets and
liabilities. SFAS 157 addresses the requests from investors for expanded
disclosure about the extent to which companies measure assets and liabilities at
fair value, the information used to measure fair value and the effect of fair
value measurements on earnings. SFAS 157 applies whenever other standards
require (or permit) assets or liabilities to be measured at fair value, and does
not expand the use of fair value in any new circumstances. SFAS 157 is effective
for financial statements issued for fiscal years beginning after November 15,
2007 and will be adopted by the Company in the first quarter of fiscal year
2009. The Company is unable at this time to determine the effect that its
adoption of SFAS 157 will have on its consolidated results of operations and
financial condition.

                                      F-10

                        ENVIRO VORAXIAL TECHNOLOGY, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                DECEMBER 31, 2006


Accounting for uncertainty in income taxes
------------------------------------------

In July 2006, the FASB issued FASB Interpretation No. 48, "Accounting for
Uncertainty in Income Taxes, an interpretation of FASB Statement No. 109" (FIN
48). FIN 48 clarifies the accounting for uncertainty in income taxes by
prescribing the recognition threshold a tax position is required to meet before
being recognized in the financial statements. It also provides guidance on
derecognition, classification, interest and penalties, accounting in interim
periods, disclosure and transition. The cumulative effects, if any, of applying
FIN 48 will be recorded as an adjustment to retained earnings as of the
beginning of the period of adoption. FIN 48 is effective for fiscal years
beginning after December 15, 2006, and the Company is required to adopt it in
the first quarter of fiscal year 2008. The Company is currently evaluating the
effect that the adoption of FIN 48 will have on its consolidated results of
operations and financial condition and is not currently in a position to
determine such effects, if any.

Taxes collected from customer and remitted to governmental authorities
----------------------------------------------------------------------

In June 2006, the FASB ratified Emerging Issues Task Force (EITF) Issue No. 06-3
(EITF 06-3), "How Taxes Collected from Customers and Remitted to Governmental
Authorities Should Be Presented in the Income Statement (That Is, Gross versus
Net Presentation)." EITF 06-3 applies to any tax assessed by a governmental
authority that is directly imposed on a revenue producing transaction between a
seller and a customer. EITF 06-3 allows companies to present taxes either gross
within revenue and expense or net. If taxes subject to this issue are
significant, a company is required to disclose its accounting policy for
presenting taxes and the amount of such taxes that are recognized on a gross
basis. The Company currently presents such taxes net. EITF 06-3 is required to
be adopted during the first quarter of fiscal year 2008. These taxes are
currently not material to the Company's consolidated financial statements.

Accounting for rental costs incurred during a construction period
-----------------------------------------------------------------

In September 2006, the FASB issued FASB Staff Position No. FAS 13-1 (As
Amended), "Accounting for Rental Costs Incurred during a Construction Period"
(FAS 13-1). This position requires a company to recognize as rental expense the
rental costs associated with a ground or building operating lease during a
construction period, except for costs associated with projects accounted for
under SFAS No. 67, "Accounting for Costs and Initial Rental Operations of Real
Estate Projects." FAS 13-1 is effective for reporting periods beginning after
December 15, 2005 and was adopted by the Company in the first quarter of fiscal
year 2007. The Company's adoption of FAS 13-1 will not materially affect its
consolidated results of operations and financial position.

                                      F-11


                        ENVIRO VORAXIAL TECHNOLOGY, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                DECEMBER 31, 2006


Effects of Prior Year Misstatements when Quantifying Misstatements in the
-------------------------------------------------------------------------
Current Year Financial Statements
---------------------------------

In September 2006, the SEC issued Staff Accounting Bulletin No. 108,
"Considering the Effects of Prior Year Misstatements when Quantifying
Misstatements in Current Year Financial Statements" (SAB 108). SAB 108 provides
guidance on the consideration of the effects of prior year misstatements in
quantifying current year misstatements for the purpose of a materiality
assessment. SAB 108 establishes an approach that requires quantification of
financial statement errors based on the effects of each on a company's balance
sheet and statement of operations and the related financial statement
disclosures. Early application of the guidance in SAB 108 is encouraged in any
report for an interim period of the first fiscal year ending after November 15,
2006, and will be adopted by the Company in the first quarter of fiscal year
2007. The Company does not expect the adoption of SAB 108 to have a material
impact on its consolidated results of operations and financial condition

FSP FAS  123(R)-5
-----------------

FSP FAS 123(R)-5 was issued on October 10, 2006. The FSP provides that
instruments that were originally issued as employee compensation and then
modified, and that modification is made to the terms of the instrument solely to
reflect an equity restructuring that occurs when the holders are no longer
employees, then no change in the recognition or the measurement (due to a change
in classification) of those instruments will result if both of the following
conditions are met: (a). There is no increase in fair value of the award (or the
ratio of intrinsic value to the exercise price of the award is preserved, that
is, the holder is made whole), or the antidilution provision is not added to the
terms of the award in contemplation of an equity restructuring; and (b). All
holders of the same class of equity instruments (for example, stock options) are
treated in the same manner. The provisions in this FSP shall be applied in the
first reporting period beginning after the date the FSP is posted to the FASB
website. The Company does not expect the adoption of FSP FAS 123(R)-5 to have a
material impact on its consolidated results of operations and financial
condition

NOTE D - CONCENTRATION OF CREDIT RISK

One customer accounted for approximately 63% of revenue for the years end
December 31, 2006. There were no outstanding receivables from this customer as
of December 31, 2006.

                                      F-12

                        ENVIRO VORAXIAL TECHNOLOGY, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                DECEMBER 31, 2006

NOTE E - FIXED ASSETS

Fixed assets as of December 31, 2006 consists of:

                                                                 2006
                                                           ---------------
Machinery and equipment                                    $       278,929
Furniture and fixtures                                              14,498
                                                           ---------------
Total                                                              293,427
Less:  accumulated depreciation                                   (288,672)
                                                           ---------------
Fixed Assets, net                                          $         4,755
                                                           ===============

Depreciation expense for the years ended December 31, 2006 and 2005 amounted to
$583 and $2,720 respectively.

NOTE F - RELATED PARTY TRANSACTIONS

For the year ended December 31, 2006, the Company incurred consulting expenses
from the chief executive officer and majority stockholder of the Company of
$175,000. Of these amounts, $75,000 has been paid out for the year ended
December 31, 2006. The unpaid balance has been included in accrued expenses.

NOTE G - CAPITAL TRANSACTIONS

Common stock
------------
In January 2005, the Company entered into a one-year consulting agreement with
its former Chief Operating Officer for engineering design, marketing and sales
of Company products and services. Pursuant to this agreement, the Company
granted 50,000 warrants to this individual exercisable at $1.00 per share. These
warrants vest equally in 12 traunches over a period of one year commencing in
January, 2005 and expire in January 2008. The Company calculated the fair value
of the warrants at the grant date by using the Black-Scholes option-pricing
model with the following weighted average assumptions: no dividend yield for all
the years; expected volatility of 133%; risk-free interest rate of 3% and an
expected life of 3 years, resulting in a fair value of approximately $21,000.

In May 2005, the Company issued 75,000 shares of common stock to a consultant,
valued at $57,000, which is based on the closing market price of the Company's
common stock on the date of the agreement. In addition, the Company paid $40,000
in cash to the consultant, which has been amortized over the life of the
consulting agreement of four months. During November 2005, the Company issued an
additional 225,000 shares per the terms of the agreement. These shares were
valued at $85,500, which is based on the closing market price of the Company's
common stock on the date of the agreement.

                                      F-13


                        ENVIRO VORAXIAL TECHNOLOGY, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                DECEMBER 31, 2006


During 2005, the Company issued 1,468,333 shares of restricted common stock at
$.40 per share, with total proceeds of $587,333 being received.

In July 2005, the Company entered into a consulting agreement. The terms of
agreement included issuance of 15,000 shares of common stock for services
rendered. The number of shares issued was based on the fair value of the
consulting services of $7,650.

In January 2006, the Company entered into a six month consulting agreement and
agreed to issue 100,000 shares for services performed by a consultant, which
were valued at $40,000.

In August 2006, the Company entered into a three month consulting agreement and
agreed to issue 100,000 shares for services performed by a consultant, which
were valued at $40,000.

In November 2006, the Company entered into a three month consulting agreement
and agreed to issue 100,000 shares for services performed by a consultant, which
were valued at $40,000.

During fiscal year 2006, the Company received gross proceeds of $893,000 from 19
accredited investors, including five investment funds to purchase an aggregate
of 2,232,500 shares of the Company's restricted common stock at $0.40 per share.

Options
-------
Information with respect to employee stock options outstanding and employee
stock options exercisable at December 31, 2006 is as follows:


                                                                                            Weighted Average
                                       Options        Vested       Exercise Price Per      Exercise Price Per
                                     Outstanding      Shares          Common Share         Option Outstanding
                                     -----------      ------          ------------         ------------------
                                                                                     
Balance, December 31, 2002            2,245,000      1,115,000         $0.15-$0.77               $0.21
Granted/vested during the year           10,000      1,120,000               $1.00

Balance, December 31, 2002            2,245,000      2,235,000         $0.15-$1.00               $0.21
Granted/vested during the year        1,424,666      1,424,666         $0.15-$1.00               $0.79

Balance, December 31, 2004            3,679,666      3,659,666         $0.15-$1.00               $0.52

Granted/vested during the year           50,000         50,000               $1.00
Balance, December 31, 2005            3,729,666      3,709,666         $0.15-$1.00               $0.52

Balance, December 31, 2006            3,729,666      3,709,666         $0.15-$1.00               $0.52

                                      F-14


                        ENVIRO VORAXIAL TECHNOLOGY, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                DECEMBER 31, 2006


The following table summarizes information about the stock options outstanding
at December 31, 2006


                      Number        Weighted       Weighted
                   Outstanding       Average        Average
     Exercise    at December 31,    Remaining       Exercise      Number Exercisable    Weighted Average
       Price          2006       Contractual Life    Price       at December 31, 2006    Exercise Price
       -----          ----       ----------------    -----       --------------------    --------------
                                                                              
        0.30          45,000           0.87           0.30                45,000                0.30
        0.77         200,000           1.13           0.77               200,000                0.77
        0.15       2,000,000           1.55           0.15             2,000,000                0.15
        1.00          10,000           1.00           1.00                10,000                1.00
        0.60         697,333           3.13           0.60               697,333                0.60
        1.00         697,333           3.13           1.00               697,333                1.00
        1.00          50,000           3.00           1.00                50,000                1.00
        0.71          30,000           1.17           0.71                30,000                0.71
                   ---------                                          ----------
                   3,729,666                                           3,729,666
                   =========                                          ==========

Warrants
--------


                                                      Number      Range of Exercise           Number
                                                   Outstanding           Price             Exercisable
                                                   -----------           -----             -----------
                                                                                    
           Balance, January 1, 2005                  5,589,367       $0.75 - $9.00           5,389,367

           Balance, December 31, 2005                5,589,367       $0.75 - $9.00           5,389,367
                                                     ---------                               ---------

           Balance, December 31, 2006                5,589,367       $0.75 - $9.00           5,389,367
                                                     ---------                               ---------

NOTE H -   INCOME TAXES

     The provision (benefit) for income taxes from continued operations for the
     years ended December 31, 2006 and 2005 consist of the following:


                                                                                       December 31,
                                                                           -------------------------------------
                                                                                2006                  2005
                                                                           ---------------       ---------------
                                                                                           
                  Current:
                           Federal                                         $             -       $             -
                           State                                                         -                     -
                                                                           $
                                                                           ---------------       ---------------
                                                                                         -                     -
                  Deferred:
                           Federal                                         $      (283,560)      $      (371,000)
                           State                                                   (50,040)              (65,000)
                                                                           ---------------       ---------------
                                                                                  (333,600)             (436,000)
                  Benefit from the operating loss
                     carryforward                                                  333,600               436,000
                                                                           ---------------       ---------------

                  Benefit for income taxes, net                            $             -       $             -
                                                                           ===============       ===============

                                      F-15

                        ENVIRO VORAXIAL TECHNOLOGY, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                DECEMBER 31, 2006


     The difference between income tax expense computed by applying the federal
     statutory corporate tax rate and actual income tax expense is as follows:


                                                                                       December 31,
                                                                              -------------------------------
                                                                                 2006                 2005
                                                                              ---------            ----------
                                                                                                  
                  Statutory federal income tax rate                               34.0%                 34.0%
                  Decrease in valuation allowance                                (40.0)%               (40.0)%
                  State income taxes                                               6.0%                  6.0%

                                                                              ---------            ----------

                  Effective tax rate                                                (0)%                  (0)%
                                                                              =========            ==========

     Deferred income taxes result from temporary differences in the recognition
     of income and expenses for the financial reporting purposes and for tax
     purposes. The net deferred tax assets and liabilities are comprised of the
     following:


                                                                                                   2006
                                                                                        -------------------------
                                                                                     
                  Deferred income tax asset:
                    Net operating loss carry-forwards                                   $               2,686,000
                     Valuation allowance                                                               (2,686,000)
                                                                                        -------------------------
                   Deferred income tax asset                                            $                       -
                                                                                        =========================


     The tax effect of these temporary differences representing deferred tax
     asset and liabilities result principally from the following:


                                                                                                    2006
                                                                                        ------------------------
                                                                                     
                  Deferred tax assets
                           Current                                                      $                     --
                           Non-current                                                                 2,686,000
                                                                                        ------------------------
                     Net deferred income tax asset                                      $              2,686,000
                                                                                        ========================

The Company has a net operating loss carryforward of approximately $6,715,000
available to offset future taxable income through 2019.

The Company has made a 100% valuation allowance of the deferred income tax asset
at December 31, 2006, as it is not expected that the deferred tax assets will be
realized. The net increase in valuation allowance during the year ended December
31, 2006 was $336,000.

                                      F-16

                        ENVIRO VORAXIAL TECHNOLOGY, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                DECEMBER 31, 2006

NOTE I - COMMITMENTS AND CONTINGENCIES

Employment Agreements
---------------------
The Company entered into an employment agreement dated January 17, 2002 with an
individual to serve as the Vice President and Director of Business Development.
The agreement provides for a contingent bonus to be paid to this employee in the
amount of $300,000 to improve the financial condition of the Company. Such bonus
is payable upon the Company obtaining a total of $3 million of financing or when
revenue exceeds $1 million. In 2002, this individual was granted stock options
to purchase 2 million shares of common stock with an exercise price of $0.15 per
share. The market price at the date of grant was $0.12 per share.

The Company hired two employees under employment agreements that commenced in
January 2003. The combined salaries for 2003 are $215,000 subject to annual
increases beginning in 2004. Both agreements have a term of 5 years. One
agreement provided for the granting of up to 300,000 cashless exercise warrants
to purchase common stock at $1 per share which may result in a significant
charge to operations in the future. This agreement was terminated by mutual
agreement on December 31, 2004, and only 150,000 warrants were vested and are
exercisable. The other agreement provides for the granting of 10,000 stock
options to purchase common stock at $1 per share exercisable ratably over two
years from the date of grant.

Operating Lease
---------------
The Company leases office and warehouse space in Ft. Lauderdale, Florida under a
business lease agreement for a three-year term ending in August 2007. Minimum
future lease payment for the following year is as follows:

                Years ending December 31,
                -------------------------
                          2007                                  $ 42,467
                                                                ========

Rent expense charged to operations amounted to $61,485 in 2006.





















                                      F-17

                        ENVIRO VORAXIAL TECHNOLOGY, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                DECEMBER 31, 2006

NOTE J - SUBSEQUENT EVENTS

Agreements and purchase orders
------------------------------
In the first quarter of 2007, we received a purchase order from a leading
Scandinavian energy company, to deploy a Voraxial Skid for a drilling operation
using lightweight drilling fluids. This technique is called "underbalanced
drilling" since it maintains the drilling operations at a lower pressure than
the formation to prevent the drilling fluids from damaging the well.

The Company received another purchase order in the first quarter of 2007 from a
leading oil and gas company in Europe to deploy a Voraxial 2000 Produced Water
Skid at one of their onshore production facilities.

In 2007, the Company signed a non-exclusive, comprehensive sales and marketing
agreement with TwinFilter, a leading Dutch filtration company in the oil and gas
industry. Under the terms of the agreement, the two companies will market and
promote each others technologies while sharing the sales & marketing expenses
and engineering expertise. Furthermore, EVTN and TwinFilter will collaborate to
build and promote turn-key oil/water and liquid/solid separation systems for the
oil industry that will incorporate EVTN's Voraxial Separator and TwinFilter's
absorption systems, coalescing, other filter technology. This agreement was
finalized after many months of collaboration to build and deliver products for
various companies within the oil industry.
































                                      F-18


YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED IN THIS DOCUMENT OR THAT WE
HAVE REFERRED YOU TO. WE HAVE NOT AUTHORIZED ANYONE TO PROVIDE YOU WITH
INFORMATION THAT IS DIFFERENT. THIS PROSPECTUS DOES NOT CONSTITUTE AN OFFER OF
ANY SECURITIES OTHER THAN THOSE TO WHICH IT RELATES OR AN OFFER TO SELL, OR A
SOLICITATION OF ANY OFFER TO BUY, TO ANY PERSON IN ANY JURISDICTION WHERE SUCH
AN OFFER OR SOLICITATION WOULD BE UNLAWFUL. NEITHER THE DELIVERY OF THIS
PROSPECTUS NOR ANY SALE MADE HEREUNDER SHALL, UNDER ANY CIRCUMSTANCES, CREATE AN
IMPLICATION THAT THE INFORMATION SET FORTH HEREIN IS CORRECT AS OF ANY TIME
SUBSEQUENT TO THE DATE HEREOF.






                                TABLE OF CONTENTS

                                                                                                                     Page
                                                                                                                     ----

                                                                                                                  
Prospectus Summary...........................................................................................          1
Forward-Looking Statements...................................................................................          4
Risk Factors.................................................................................................          4
Capitalization...............................................................................................          9
Price Range of common stock and Dividend Policy..............................................................         10
Use of Proceeds..............................................................................................         11
Management's Discussion and Analysis or Plan of Operation....................................................         12
Business.....................................................................................................         15
Management...................................................................................................         20
Certain Transactions.........................................................................................         23
Principal Shareholders.......................................................................................         24
Description of Securities....................................................................................         25
Selling Shareholders.........................................................................................         26
Plan of Distribution.........................................................................................         38
Shares Eligible for Future Sale..............................................................................         39
Legal Matters................................................................................................         39
Experts......................................................................................................         39
Additional Information.......................................................................................         39
Financial Statements.........................................................................................        F-1

















                                9,543,363 Shares






                        Enviro Voraxial Technology, Inc.







                                 -------------
                                   PROSPECTUS
                                 -------------





                              _______________, 2007



















                                    PART TWO

                     INFORMATION NOT REQUIRED IN PROSPECTUS

ITEM 24. INDEMNIFICATION OF DIRECTORS AND OFFICERS

         The Idaho Statutes (the "Idaho Statutes") permits the indemnification
of directors, employees, officers and agents of Idaho corporations. Our Articles
of Incorporation (the "Articles") and Bylaws provide that we shall indemnify its
directors and officers to the fullest extent permitted by the Idaho Statutes.

         The provisions of the Idaho Statutes that authorize indemnification do
not eliminate the duty of care of a director, and in appropriate circumstances
equitable remedies such as injunctive or other forms of non-monetary relief will
remain available under Idaho. In addition, each director will continue to be
subject to liability for (a) violations of criminal laws, unless the director
had reasonable cause to believe his conduct was lawful or had no reasonable
cause to believe his conduct was unlawful, (b) deriving an improper personal
benefit from a transaction, (c) voting for or assenting to an unlawful
distribution and (d) willful misconduct or conscious disregard for our best
interests in a proceeding by or in the right of a shareholder. The statute does
not affect a director's responsibilities under any other law, such as the Idaho
securities laws.

         The effect of the foregoing is to require us to indemnify our officers
and directors for any claim arising against such persons in their official
capacities if such person acted in good faith and in a manner that he reasonably
believed to be in or not opposed to the best interests of the corporation and,
with respect to any criminal action or proceeding, had no reasonable cause to
believe his conduct was unlawful.

         Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to our directors, officers or persons in control
pursuant to the foregoing provisions, we have been informed that in the opinion
of the Securities and Exchange Commission, such indemnification is against
public policy as expressed in the act and is therefore unenforceable.


Item  25. Other Expenses of Issuance and Distribution

         The estimated expenses payable by us in connection with the
distribution of the securities being registered are as follows:


                                                                                                      
         SEC Registration and Filing Fee.............................................................    $      293.09
         Legal Fees and Expenses*....................................................................        30,000.00
         Accounting Fees and Expenses*...............................................................         5,000.00
         Financial Printing*.........................................................................         5,000.00
         Transfer Agent Fees*........................................................................         1,000.00
         Blue Sky Fees and Expenses*.................................................................         1,000.00
         Miscellaneous*..............................................................................         5,000.00
                                                                                                         -------------
              TOTAL..................................................................................    $   47,293.09
                                                                                                         =============

------------------
     *     Estimated





                                      II-1

         None of the foregoing expenses are being paid by the selling
shareholders.

ITEM 26. RECENT SALES OF UNREGISTERED SECURITIES

         In April 2001, we raised $100,000 through the private placement of our
securities pursuant to Regulation D of the Securities Act. We sold 1,000 units
containing share of our common stock and warrants to 1 investor. Each unit was
comprised of 100 shares of restricted common stock, par value $.001, and 200
common stock purchase warrants, of which 100 warrants are exercisable at $3.00
per share and 100 warrants are exercisable at $4.00 per share. The warrants
expire April 2007. The transaction was exempt from registration under Section
4(2) of the Securities Act.

         In July 2001, we raised $20,000 through a private transaction whereby
the Company issued 23,530 shares of restricted common stock at $.85 per share to
an individual investor. The transaction was exempt from registration under
Section 4(2) of the Securities Act.

         On January 17, 2002, we issued options to purchase 2,000,000 shares of
our common stock at an exercise price of $.15 per share. The market price at the
date of the grant was $.12 per share. These options were issued pursuant to an
employment agreement. In addition, during year ended December 31, 2002, we also
issued stock options to purchase 200,000 shares of common stock to an additional
employee of our Company. These options have an exercise price of $.77 per share.

         On December 31, 2002, we issued 6,000,000 shares of common stock to
Alberto DiBella pursuant to the automatic conversion rights of the preferred
stock held by Mr. DiBella. The 6,000,000 shares of preferred stock held by Mr.
DiBella were returned to treasury and cancelled.

         During the year ended December 31, 2002, we sold 5.17 units of
securities at $60,000 per unit in a private placement to 5 investors. Each unit
consisted of 100,000 shares of common stock, 100,000 warrants to purchase
100,000 shares of common stock at an exercise price of $1 per share and 100,000
warrants to purchase 100,000 shares of common stock at an exercise price of
$1.25 per share. The warrants issued at $1 per share are callable at par value
provided the stock trades above $1.50 per share for 20 consecutive trading days.
The warrants issued at $1.25 per share are callable at par value provided the
stock trades above $2 per share for 20 consecutive trading days. Net proceeds
received by our Company aggregated $286,000. The warrants are exercisable from
the date of issuance through December 2007. No warrants have been exercised
through December 31, 2002. The transaction was exempt from registration under
Section 4(2) of the Securities Act.

         During the year ended December 2003, we sold an aggregate of 8.08 units
of securities to 30 investors for proceeds of $808,000. Each unit consisted of
166,666 shares of restricted common stock at $0.60 per share and 166,666
warrants to purchase 166,666 shares of common stock at $1.00 per share. The
warrants are exercisable for a period of five years from the date of closing.
The investors received information concerning our company and had the
opportunity to ask questions to the viability of our company. A total of
1,346,665 warrants were issued in this Offering. The issuances were exempt from
registration under Section 4(2) of the Securities Act. The investors received
information concerning the Company and had the opportunity to ask questions
concerning the viability of the Company. The shares contain legends restricting
their transferability absent registration or applicable exemption.

         In January 2004, we closed a private placement, which commenced in
2003. Under the private placement we sold an aggregate of 61,666 shares of
                                      II-2

restricted common stock at $0.60 per share and 61,666 warrants to purchase
61,666 shares of common stock at $1.00 per share to four investors for proceeds
of $37,000. The warrants are exercisable for a period of five years from the
date of closing. The transactions were exempt from registration under Section
4(2) of the Securities Act. The investors received information concerning the
Company and had the opportunity to ask questions concerning the viability of the
Company. The shares and warrants contain legends restricting their
transferability absent registration or applicable exemption.

         From May 2004 through August 2004, the Company sold an aggregate of
1,935,000 units of securities to 38 accredited investors for gross proceeds of
$1,451,250 under the private placement. The Company has paid Bathgate Capital, a
placement agent, a commission of 10% of the gross proceeds and a non-accountable
expense allowance of 3% of the gross proceeds and issued the placement agent
warrants to purchase six shares of common stock (three shares at $0.75 and three
shares at $1.00) for each 20 units sold in the offering. Each unit consisted of
one share of restricted common stock at $0.75 per share and one warrant to
purchase one share of common stock at $1.00 per share. The warrants are
exercisable for a period of five years from the date of closing. The
transactions were exempt from registration under Regulation D, Rule 506 of the
Securities Act. All of the investors were deemed accredited. The investors
received information concerning the Company and had the opportunity to ask
questions concerning the viability of the Company. The shares and warrants
contain legends restricting their transferability absent registration or
applicable exemption.

         On June 30, 2004, we issued 7,100 shares of our common stock to an
individual in consideration for services rendered. The shares were issued
pursuant to the exemption from registration under Section 4(2) of the Securities
Act. The service provider received information concerning the Company and had
the opportunity to ask questions concerning the Company. The shares issued
contain a legend restricting transferability absent registration or applicable
exemption.

         During fiscal year 2005, the Company received capital from ten
accredited investors to purchase an aggregate of 1,468,333 shares of the
Company's restricted common stock at $0.40 per share for gross proceeds of
$587,333. The issuances were exempt from registration under Section 4(2) of the
Securities Act. Commissions paid to registered brokers and other expenses
related to the Offering were approximately $50,000. The investors received
information concerning the Company and has the opportunity to ask questions
concerning the viability of the Company. The shares contain legends restricting
their transferability absent registration or applicable exemption.

         In May 2005, the Company issued 75,000 shares of common stock to a
consultant valued at $57,000 based on the closing market price of the Company's
common stock on the date of the agreement. In addition, the Company paid $40,000
in cash to this consultant. These amounts are amortized over the life of the
consulting agreement of four months, resulting in consulting expense of $97,000
for the nine months ended September 30, 2005. In November 2005, this consultant
received another 225,000 shares of common stock valued at $85,500 based on the
closing market price of the Company's common stock on the date of the agreement.
The shares were issued pursuant to the exemption from registration under Section
4(2) of the Securities Act. The consultant received information concerning the
Company and had the opportunity to ask questions concerning the Company. The
shares issued contain a legend restricting transferability absent registration
or applicable exemption.

         On July 1, 2005, the Company entered into a consulting agreement and
agreed to issue 15,000 shares for services performed by a consultant, which were

                                      II-3

valued at $7,650. The shares were issued pursuant to the exemption from
registration under Section 4(2) of the Securities Act. The service provider
received information concerning the Company and had the opportunity to ask
questions concerning the Company. The shares issued contain a legend restricting
transferability absent registration or applicable exemption.

         In January 2006, we extended the exercisable life of certain warrants
to purchase an aggregate of 243,200 shares of common stock issued in 2000 for a
period of one year. The options initially expired in February 2007, but were
extended on January 16, 2007 and now expire in February 2008. In January 2007,
we also extended the exercisable life of certain warrants to purchase an
aggregate of 200,000 shares of common stock issued in 2001. The warrants now
expire in April 2008.

         In January 2006, the Company entered into a six month consulting
agreement and agreed to issue 100,000 shares for services performed by a
consultant, which were valued at $40,000. The shares were issued pursuant to the
exemption from registration under Section 4(2) of the Securities Act. The
consultant received information concerning the Company and had the opportunity
to ask questions concerning the Company. The shares issued contain a legend
restricting transferability absent registration or applicable exemption.

         In August 2006, the Company entered into a three month consulting
agreement and agreed to issue 100,000 shares for services performed by a
consultant, which were valued at $40,000. The shares were issued pursuant to the
exemption from registration under Section 4(2) of the Securities Act. The
consultant received information concerning the Company and had the opportunity
to ask questions concerning the Company. The shares issued contain a legend
restricting transferability absent registration or applicable exemption.

         In November 2006, the Company entered into a three month consulting
agreement and agreed to issue 100,000 shares for services performed by a
consultant, which were valued at $40,000. The shares were issued pursuant to the
exemption from registration under Section 4(2) of the Securities Act. The
consultant received information concerning the Company and had the opportunity
to ask questions concerning the Company. The shares issued contain a legend
restricting transferability absent registration or applicable exemption.

         During the twelve months ended December 30, 2006 the Company sold
2,232,500 shares of common stock for $0.40 per share in a private placement
offering to 19 accredited investors. Total proceeds from the sale were $893,000.
The issuances were exempt from registration under Section 4(2) of the Securities
Act. Commissions paid to registered brokers and other expenses were
approximately $30,000. The investors received information concerning the Company
and had the opportunity to ask questions concerning the viability of the
Company. The shares contain legends restricting their transferability absent
registration or applicable exemption.

[TO COME]

ITEM 27.  EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

Exhibit No.       Description of Document
-----------       -----------------------
     2.1          Agreement and Plan of Reorganization dated May 1996 (1)
     3.1          Articles of Incorporation, as amended (1)
     3.2          Bylaws (1)
     4.1          Form of Stock Certificate (1)

     5.1          Opinion of Arnstein & Lehr LLP

                                      II-4

     10.1         Form of Warrant Agreement (previously filed)
     10.2         Form of Option Agreement (previously filed)
     16.1         Letter from former independent accountant (2)
     23.1         Consent of Current Independent Auditor (filed herein)
     23.2         Consent of Arnstein & Lehr LLP  (included in exhibit 5.1)

(1)      Previously filed on Form 10SB Registration Statement, as amended, on
         January 19, 2000 (file 000-30454).
(2)      Previously filed on Form 8-K Current Report dated March 14, 2005.

ITEM 28. UNDERTAKINGS

         The undersigned Registrant undertakes:

(1) To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement:

                  (i) To include any prospectus required by section 10(a)(3) of
              the Securities Act of 1933;

                  (ii) To reflect in the prospectus any facts or events arising
              after the effective date of the registration statement (or the
              most recent post-effective amendment thereof) which, individually
              or in the aggregate, represent a fundamental change in the
              information set forth in the registration statement;

                  (iii) To include any material information with respect to the
              plan of distribution not previously disclosed in the registration
              statement or any material change to such information in the
              registration statement;

         Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not
apply if the registration statement is on Form S-3 or Form S-8, and the
information required to be included in a post-effective amendment by those
paragraphs is contained in periodic reports filed by the registrant pursuant to
section 13 or section 15(d) of the Securities Exchange Act of 1934 that are
incorporated by reference in the registration statement.

(2) That, for the purpose of determining any liability under the Securities Act
of 1933, each such post-effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.

(3) To remove from registration by means of a post-effective amendment any of
the securities being registered which remain unsold at the termination of the
offering.

         Insofar as indemnification for liabilities arising under the Securities
Act of 1933 (the "Securities Act") may be permitted to directors, officers and
controlling persons of the registrant pursuant to the foregoing provisions, or
otherwise, the Registrant has been advised that in the opinion of the Securities
and Exchange Commission (the "Commission") such indemnification is against
public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such
liabilities (other than the payment by the Registrant of expenses incurred or
paid by a director, officer or controlling person of the Registrant in the
                                      II-5

successful defense of any action, suit or preceding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.

         Each prospectus filed pursuant to Rule 424(b) as part of a registration
statement relating to an offering, other than registration statements relying on
Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be
deemed to be part of and included in the registration statement as of the date
it is first used after effectiveness. Provided, however, that no statement made
in a registration statement or prospectus that is part of the registration
statement or made in a document incorporated or deemed incorporated by reference
into the registration statement or prospectus that is part of the registration
statement will, as to a purchaser with a time of contract of sale prior to such
first use, supersede or modify any statement that was made in the registration
statement or prospectus that was part of the registration statement or made in
any such document immediately prior to such date of first use.









































                                      II-6

                                   SIGNATURES

         Pursuant to the requirements of the Securities Act of 1933, as amended,
the registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on this Form SB-2 and authorized this
registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in Fort Lauderdale, Florida on November 28, 2007.


                                        ENVIRO VORAXIAL TECHNOLOGY, INC.

                                        By:/s/ Alberto Dibella
                                        ----------------------
                                        Alberto DiBella, Chief Executive Officer

         Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons in the
capacities and on the dates indicated.

   Signature                       Title                       Date
   ---------                       -----                       ----

/s/Alberto DiBella          Chief Executive Officer          November 28, 2007
------------------          (principal executive officer)
Alberto DiBella             and Chief Financial Officer
                            (principal financial and
                            accounting officer)


/s/John A. DiBella          Vice President and Director      November 28, 2007
------------------
John A. DiBella



























                                      II-7